STOCK TITAN

Quantum X posts $2.93M loss, warns on going concern

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Quantum X, Inc. (QUTX) reported no revenue and a net loss of $2,927,672 for the nine months ended September 30, 2026, compared with a $1,083,086 loss a year earlier. It used $868,710 in operating cash and had $79,508 cash and a $3,065,331 working-capital deficit at quarter-end. Management said these conditions raise substantial doubt about its ability to continue as a going concern. Quantum X estimates $1,070,000 in cash expenditures over the next 12 months and is discussing private loans and an equity line of credit.

Quantum X is shifting toward AI and quantum-computing software; its Pegasus, Scalova and EntangleX products had not reached a marketable stage. After quarter-end, it signed a binding letter of intent to acquire 80% of UK-based TraderMade Systems from Currency Mountain Holdings, LLC, which is owned by CEO Emil Assentato. Proposed consideration is 550,000,000 QUTX shares at US$0.001 each, alongside the seller’s rights to a GBP £412,162 receivable plus accrued interest. Closing is subject to customary conditions and an independent valuation confirming at least US$550,000 in combined value for the acquired shares and receivable.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 3 points

How the balance works

Positive

  • None.

Negative

  • Major pointGoing-concern risk: management cites substantial doubt about the company’s ability to continue.
  • Major pointNine-month net loss rose: $2.93 million versus $1.08 million in 2025.
  • Moderate pointOperating cash use: $868,710, up from $492,840 in 2025.

Filing Explained

At September 30, 2026, another 2,013,730,387 shares were potentially issuable under convertible notes, separate from shares already issued.

This Form 10-Q is the unaudited quarterly report, and it reports Quantum X, Inc.’s share capital and interim results through September 30, 2026. Common shares outstanding were 6,501,509,691 at December 31, 2025 and 7,697,746,967 at September 30, 2026; the company reports issuances for compensation and services, a related-party liability settlement, and convertible-note settlement during the nine-month period. Those issuances increase the share count and reduce existing holders’ percentage ownership, absent offsetting changes.

Separately, the company says 2,013,730,387 shares issuable on conversion of non-redeemable and convertible promissory notes were excluded from diluted loss per share at September 30 because their effect would have been anti-dilutive; these are potential conversion shares, not shares reported as issued. The July 6 and September 15 notes become convertible at the holder’s option after 180 days, at a price based on 75% of the average of the three lowest closing bid prices during the prior ten trading days.

Revenue $0 Nine months ended September 30, 2026; the company reported no revenue.
Net loss ($2,927,672) Nine months ended September 30, 2026; compared with ($1,083,086) in 2025.
Cash used in operating activities ($868,710) Nine months ended September 30, 2026; compared with ($492,840) in 2025.
Cash $79,508 As of September 30, 2026.
Working-capital deficit ($3,065,331) As of September 30, 2026.
Estimated cash expenditures Approximately $1,070,000 Expected over the next 12 months for operations, legal, accounting and related services, and to implement the business plan.
Proposed TraderMade acquisition consideration US$550,000, payable in 550,000,000 shares at US$0.001 per share Binding letter of intent to acquire 80%, subject to an independent valuation and customary closing conditions.
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
variable conversion price financial
"variable conversion price calculated as 75% of the average"
derivative liability financial
"recorded as a derivative liability and a corresponding debt discount"
A derivative liability is an obligation a company owes because of a derivatives contract—such as an option, future, swap, or forward—that has moved against it and now has negative value. Think of it like a settled bet that turned into a bill: if market moves go the other way, the company may have to pay cash or deliver assets. Investors care because these liabilities can create sudden losses, add leverage or counterparty risk, and change a company’s true financial exposure beyond its everyday operations.
anti-dilutive financial
"their effect would have been anti-dilutive"
A claim, security feature, or action described as anti-dilutive prevents or does not cause a reduction in existing shareholders’ per-share values when additional shares could be issued. For example, certain convertible securities or corporate actions are treated as anti-dilutive for earnings-per-share calculations if including them would raise EPS rather than lower it; investors watch this because it affects reported per-share metrics, ownership percentages, and valuation comparisons, like keeping pie slices the same size instead of making them smaller.
capitalized software development costs technical
"Capitalized software development costs were $20,000"
Costs for creating or enhancing internal-use or sold software that a company records as an asset on the balance sheet instead of expensing immediately. Like treating the purchase of a long-lasting tool as an investment rather than a one-time bill, these costs are spread out as non-cash depreciation over future periods. Investors watch this because it boosts current profits and reported assets, changing growth and margin comparisons and sometimes masking true cash profitability.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue and net loss did QUTX report for the first nine months of 2026?

Quantum X reported no revenue and a net loss of $2,927,672 for the nine months ended September 30, 2026. The year-earlier net loss was $1,083,086.

Why did QUTX report substantial doubt about continuing as a going concern?

Quantum X said its financial condition raises substantial doubt about its ability to continue as a going concern for one year from issuance of the financial statements. It reported a nine-month loss of $2,927,672, operating cash use of $868,710 and a stockholders’ deficit of $2,631,455.

What are the terms of QUTX’s proposed TraderMade acquisition?

Quantum X signed a binding letter of intent to acquire 80% of TraderMade from Currency Mountain Holdings, LLC, which is owned by CEO Emil Assentato. Proposed consideration is 550,000,000 shares at US$0.001 each, plus rights to a GBP £412,162 receivable and accrued interest. Closing requires an independent valuation and satisfaction of customary conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --12-31 2026 Q3 0001494413 0001494413 2026-01-01 2026-09-30 0001494413 2026-11-11 0001494413 2026-09-30 0001494413 2025-12-31 0001494413 2026-07-01 2026-09-30 0001494413 2025-07-01 2025-09-30 0001494413 2025-01-01 2025-09-30 0001494413 us-gaap:CommonStockMember 2026-06-30 0001494413 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001494413 us-gaap:RetainedEarningsMember 2026-06-30 0001494413 2026-06-30 0001494413 us-gaap:CommonStockMember 2025-12-31 0001494413 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001494413 us-gaap:RetainedEarningsMember 2025-12-31 0001494413 us-gaap:CommonStockMember 2025-06-30 0001494413 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001494413 us-gaap:RetainedEarningsMember 2025-06-30 0001494413 2025-06-30 0001494413 us-gaap:CommonStockMember 2024-12-31 0001494413 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001494413 us-gaap:RetainedEarningsMember 2024-12-31 0001494413 2024-12-31 0001494413 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001494413 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0001494413 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001494413 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001494413 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-09-30 0001494413 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001494413 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001494413 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001494413 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001494413 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001494413 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-09-30 0001494413 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001494413 us-gaap:CommonStockMember 2026-09-30 0001494413 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0001494413 us-gaap:RetainedEarningsMember 2026-09-30 0001494413 us-gaap:CommonStockMember 2025-09-30 0001494413 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001494413 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001494413 us-gaap:RetainedEarningsMember 2025-09-30 0001494413 2025-09-30 0001494413 us-gaap:ComputerEquipmentMember 2026-01-01 2026-09-30 0001494413 qutx:NonRedeemableConvertibleNotesMember 2026-01-01 2026-09-30 0001494413 qutx:ConvertiblePromissoryNotesMember 2026-01-01 2026-09-30 0001494413 qutx:NonRedeemableConvertibleNotesMember 2025-01-01 2025-09-30 0001494413 qutx:ConvertibleNotesMember 2025-01-01 2025-09-30 0001494413 us-gaap:FairValueInputsLevel1Member 2026-09-30 0001494413 us-gaap:FairValueInputsLevel2Member 2026-09-30 0001494413 us-gaap:FairValueInputsLevel3Member 2026-09-30 0001494413 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001494413 us-gaap:FairValueInputsLevel2Member 2025-12-31 0001494413 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-12-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2026-01-01 2026-09-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2026-09-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-12-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-01-01 2025-09-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-09-30 0001494413 qutx:GraphicsProcessingUnitMember 2026-09-30 0001494413 qutx:GraphicsProcessingUnitMember 2025-12-31 0001494413 us-gaap:ComputerEquipmentMember 2026-09-30 0001494413 us-gaap:ComputerEquipmentMember 2025-12-31 0001494413 qutx:SideLetterAgreementMember qutx:NonRedeemableConvertibleNotesPayableMember qutx:JordanTurkMember 2026-01-01 2026-09-30 0001494413 qutx:SideLetterAgreementMember qutx:NonRedeemableConvertibleNotesPayableMember qutx:JordanTurkMember 2018-09-13 0001494413 qutx:SideLetterAgreementMember qutx:NonRedeemableConvertibleNotesPayableMember qutx:JordanTurkMember 2018-09-12 2018-09-13 0001494413 qutx:NewPromissoryNoteMember qutx:JordanTurkMember 2024-12-29 2024-12-30 0001494413 qutx:NewPromissoryNoteMember qutx:JordanTurkMember 2024-12-30 0001494413 qutx:NewPromissoryNoteMember qutx:JordanTurkMember srt:ChiefExecutiveOfficerMember 2024-12-30 0001494413 qutx:SideLetterAgreementMember qutx:NonRedeemableConvertibleNotesPayableMember qutx:JordanTurkMember 2025-01-01 2025-09-30 0001494413 qutx:NonRedeemableConvertibleNotesPayableMember qutx:SideLetterAgreementMember qutx:JordanTurkMember 2026-09-30 0001494413 qutx:NonRedeemableConvertibleNotesPayableMember qutx:SideLetterAgreementMember qutx:JordanTurkMember 2025-12-31 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2025-11-12 2025-11-13 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2025-11-13 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-05-14 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-05-13 2026-05-14 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-01-01 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2025-01-01 2025-12-31 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2025-12-01 2025-12-02 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2025-12-02 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-06-02 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-06-01 2026-06-02 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupInc1Member qutx:ConvertiblePromissoryNotesMember 2026-01-01 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupInc1Member qutx:ConvertiblePromissoryNotesMember 2025-01-01 2025-12-31 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupInc1Member qutx:ConvertiblePromissoryNotesMember 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-01-15 2026-01-16 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-01-16 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-08-05 2026-08-06 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupInc1Member qutx:ConvertiblePromissoryNotesMember 2026-08-05 2026-08-06 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupInc1Member qutx:ConvertiblePromissoryNotesMember 2026-08-06 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:ConvertiblePromissoryNotesMember 2026-08-06 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupInc2Member qutx:ConvertiblePromissoryNotesMember 2026-01-01 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupInc2Member qutx:ConvertiblePromissoryNotesMember 2025-01-01 2025-12-31 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:ConvertiblePromissoryNotesMember 2026-07-05 2026-07-06 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:ConvertiblePromissoryNotesMember 2026-07-06 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:ConvertiblePromissoryNotesMember 2026-01-01 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:ConvertiblePromissoryNotesMember 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:ConvertiblePromissoryNotesMember 2026-09-14 2026-09-15 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:ConvertiblePromissoryNotesMember 2026-09-15 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:ConvertiblePromissoryNotes1Member 2026-01-01 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:ConvertiblePromissoryNotes1Member 2026-09-30 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember 2026-05-20 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember 2026-05-19 2026-05-20 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember qutx:November302026Member 2026-05-19 2026-05-20 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember qutx:December302026Member 2026-05-19 2026-05-20 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember qutx:January302027Member 2026-05-19 2026-05-20 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember qutx:February282027Member 2026-05-19 2026-05-20 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember qutx:March302027Member 2026-05-19 2026-05-20 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember 2026-07-17 0001494413 qutx:SecuritiesPurchaseAgreementMember qutx:VanquishFundingGroupIncMember qutx:PromissoryNoteMember 2026-07-16 2026-07-17 0001494413 qutx:PromissoryNoteMember qutx:NewNoteMember 2026-09-30 0001494413 qutx:PromissoryNoteMember qutx:NewNoteMember 2026-01-01 2026-09-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-09-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-09-15 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-07-17 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-07-06 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-06-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-03-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember srt:MinimumMember 2026-01-01 2026-09-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember srt:MaximumMember 2026-01-01 2026-09-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-09-14 2026-09-15 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-07-16 2026-07-17 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-07-05 2026-07-06 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-06-29 2026-06-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-01-01 2026-03-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember srt:MinimumMember 2026-01-01 2026-03-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember srt:MaximumMember 2026-01-01 2026-03-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-01-01 2026-09-30 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-01-16 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2025-12-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2025-12-02 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2025-11-13 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2026-01-15 2026-01-16 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2025-01-01 2025-12-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2025-12-01 2025-12-02 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2025-11-12 2025-11-13 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember srt:MinimumMember 2025-01-01 2025-12-31 0001494413 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember srt:MaximumMember 2025-01-01 2025-12-31 0001494413 srt:ChiefExecutiveOfficerMember 2026-01-01 2026-09-30 0001494413 srt:ChiefExecutiveOfficerMember 2026-09-30 0001494413 qutx:CEOCFOAndDirectorMember 2026-01-01 2026-09-30 0001494413 qutx:CEOCFOAndDirectorMember 2025-01-01 2025-09-30 0001494413 2026-04-30 2026-05-01 0001494413 qutx:EntangleXMember 2026-04-30 2026-05-01 0001494413 qutx:ScalovaMember 2026-04-30 2026-05-01 0001494413 qutx:RoyMember 2026-07-01 2026-09-30 0001494413 qutx:RoyMember 2026-01-01 2026-09-30 0001494413 qutx:EntangleXMember 2026-07-01 2026-09-30 0001494413 qutx:EntangleXMember 2026-01-01 2026-09-30 0001494413 srt:ChiefExecutiveOfficerMember qutx:StockIncentive2026PlanMember 2026-01-01 2026-09-30 0001494413 srt:ChiefExecutiveOfficerMember qutx:StockIncentive2026PlanMember 2026-09-30 0001494413 us-gaap:PreferredStockMember 2026-09-30 0001494413 us-gaap:SeriesAPreferredStockMember 2013-08-06 0001494413 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-09-30 0001494413 us-gaap:SeriesBPreferredStockMember 2019-12-12 0001494413 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-09-30 0001494413 us-gaap:SeriesCPreferredStockMember 2020-10-07 0001494413 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-09-30 0001494413 us-gaap:SeriesCPreferredStockMember srt:MinimumMember 2021-06-24 0001494413 us-gaap:SeriesCPreferredStockMember srt:MaximumMember 2021-06-24 0001494413 us-gaap:SeriesCPreferredStockMember 2022-04-26 2022-04-27 0001494413 us-gaap:SeriesCPreferredStockMember srt:MinimumMember 2022-04-27 0001494413 us-gaap:SeriesCPreferredStockMember srt:MaximumMember 2022-04-27 0001494413 us-gaap:SeriesCPreferredStockMember srt:MaximumMember 2022-06-29 2022-06-30 0001494413 us-gaap:SeriesCPreferredStockMember srt:MinimumMember 2022-06-29 2022-06-30 0001494413 us-gaap:SeriesDPreferredStockMember 2021-09-01 0001494413 us-gaap:SeriesDPreferredStockMember 2026-01-01 2026-09-30 0001494413 us-gaap:SeriesEPreferredStockMember 2022-10-04 0001494413 us-gaap:SeriesEPreferredStockMember 2022-10-03 2022-10-04 0001494413 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001494413 us-gaap:CommonStockMember 2026-09-30 0001494413 qutx:StockIncentive2026PlanMember 2026-01-01 2026-09-30 0001494413 qutx:StockIncentive2026PlanMember 2026-09-30 0001494413 qutx:ConsultingAndCorporateAdvisoryServicesMember 2026-01-01 2026-09-30 0001494413 qutx:ConsultingAndCorporateAdvisoryServicesMember 2026-09-30 0001494413 qutx:EntangleXMember 2026-01-01 2026-09-30 0001494413 2026-04-30 2026-05-31 0001494413 qutx:EntangleXMember 2026-04-30 2026-05-31 0001494413 qutx:ScalovaMember 2026-04-30 2026-05-31 0001494413 qutx:UjjwalRoyMember 2026-04-30 2026-05-31 0001494413 qutx:EntangleXMember 2026-09-30 0001494413 qutx:MoreCapitalLtdMember 2025-07-14 0001494413 qutx:MoreCapitalLtdMember 2025-07-10 2025-07-14 0001494413 qutx:TraderMadeSystemsLtdMember us-gaap:SubsequentEventMember 2026-10-05 0001494413 qutx:TraderMadeSystemsLtdMember us-gaap:SubsequentEventMember 2026-10-05 0001494413 qutx:TraderMadeSystemsLtdMember us-gaap:SubsequentEventMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-10-04 2026-10-05 0001494413 qutx:TraderMadeSystemsLtdMember us-gaap:SubsequentEventMember 2026-10-04 2026-10-05 0001494413 qutx:TraderMadeSystemsLtdMember us-gaap:SubsequentEventMember 2026-10-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure qutx:Integer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

OR

 

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to __________

 

Commission File Number: 333-167667

 

QUANTUM X, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   33-4429767
(State or Other Jurisdiction of   (I.R.S. Employer
Incorporation or Organization)   Identification No.)

 

141 Piping Rock Road
Locust Valley, New York

(Address of Principal Executive Offices)

 

 

11560

(Zip Code)

 

     

(516) 384-8577

(Registrant's telephone number, including area code)

 

Two Hands Corporation

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer               ¨ Accelerated filer                          ¨
Non-accelerated filer            x Smaller reporting company     x
Emerging growth company          ¨    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

 Securities registered under Section 12(b) of the Act:

Title of each class Name of each exchange on which registered
          N/A                              N/A

 1 
 

Securities registered under Section 12(g) of the Act:

Common Stock, $.0001 Par Value

(Title of class)

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of November 11, 2026 the issuer had 7,697,746,967 shares of its common stock issued and outstanding, par value $0.0001 per share.

 2 
 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This report on Form 10-Q contains "forward-looking statements" that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in our Form 10-K filed on April 10, 2026, and other filings we make with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law.

 

The following discussion and analysis of financial condition and results of operations is based upon and should be read in conjunction with our audited financial statements and related notes thereto included in our Form 10-K filed on April 10, 2026.

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 
 

QUANTUM X, INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

PART I   PAGE
Item 1. Financial Statements (Unaudited) 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21
Item 3. Quantitative and Qualitative Disclosures About Market Risk 30
Item 4. Controls and Procedures 30
PART II    
Item 1. Legal Proceedings 31
Item 1A. Risk Factors 31
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31
Item 3. Defaults Upon Senior Securities 31
Item 4. Mining Safety Disclosures 31
Item 5. Other Information 31
Item 6. Exhibits 32
  Signatures 33

 

 4 
 

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements. 

QUANTUM X, INC.
(FORMERLY KNOWN AS TWO HANDS CORPORATION)
CONDENSED CONSOLIDATED BALANCE SHEETS

           
   September 30, 2026  December 31, 2025
   (Unaudited)   
ASSETS      
       
Current assets          
Cash  $79,508   $227,585 
VAT taxes receivable   25,088    22,057 
Prepaid expenses   141,564    4,594 
Total current assets   246,160    254,236 
           
Property and equipment, net   151,989    4,392 
Capitalized software development costs   20,000    —   
Deposits   261,887    60,000 
           
Total assets  $680,036   $318,628 
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
Current liabilities          
Accounts payable and accrued liabilities  $579,162   $552,612 
Accrued liabilities - related party   170,417    192,417 
Note payable - related party   1,959,777    882,632 
Notes payable   114,736    118,978 
Non-redeemable convertible note, net - related party   137,951    120,000 
Convertible promissory notes, net   135,948    2,598 
Derivative liabilities   213,500    395,464 
Total current liabilities   3,311,491    2,264,701 
           
Total liabilities   3,311,491    2,264,701 
           
Commitments and Contingencies   —      —   
           
Stockholders' deficit          
Preferred stock; 1,000,000 shares authorized, 0 issued and outstanding   —      —   
Common stock; $0.0001 par value; 12,000,000,000 shares authorized,  7,697,746,967 and 6,501,509,691 shares issued and outstanding, respectively   769,775    650,152 
Additional paid-in capital   94,427,194    92,324,398 
Accumulated other comprehensive income   104,250    84,379 
Accumulated deficit   (97,932,674)   (95,005,002)
Total stockholders' deficit   (2,631,455)   (1,946,073)
           
Total liabilities and stockholders' deficit  $680,036   $318,628 
           
The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

 5 
 

QUANTUM X, INC.
(FORMERLY KNOWN AS TWO HANDS CORPORATION)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(Unaudited)

 

                     
    For the three months ended September 30,    For the nine months ended September 30, 
    2026    2025    2026    2025 
                     
Revenue  $—     $—     $—     $—   
                     
Operating expenses                    
General and administrative   559,674    259,977    2,871,792    724,648 
Total operating expenses   559,674    259,977    2,871,792    724,648 
                     
Loss from operations   (559,674)   (259,977)   (2,871,792)   (724,648)
                     
Other income (expense)                    
Amortization of debt discount and interest expense   (109,763)   (183,629)   (230,595)   (321,941)
Gain (loss) on settlement of debt        (17,181)   5,272    (17,181)
Initial derivative expense   —      —      (33,804)   (235,220)
Change in fair value of derivative liabilities   8,400    44,451    219,239    215,904 
Write-off of advances   (15,992)   —      (15,992)   —   
     Total other income (expense)   (117,355)   (156,359)   (55,880)   (358,438)
                     
Net loss   (677,029)   (416,336)   (2,927,672)   (1,083,086)
Other comprehensive income (loss)                    
Foreign currency translation adjustment   (204)   12,218    19,871    (22,843)
    Total other comprehensive income (loss)   (204)   12,218    19,871    (22,843)
                     
Comprehensive loss  $(677,233)  $(404,118)  $(2,907,801)  $(1,105,929)
                     
Loss per common share - basic and diluted  $(0.00)  $(0.00)  $(0.00)  $(0.00)
Weighted average number of common shares outstanding - basic and diluted   7,646,814,797    5,712,734,623    7,034,073,365    5,587,944,630 
                     
The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

 6 
 

QUANTUM X, INC.
(FORMERLY KNOWN AS TWO HANDS CORPORATION)
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three and nine months ended September 30, 2026 and 2025
(Unaudited)

                               
    Common Stock   Additional Paid-in    Accumulated Other Comprehensive    Accumulated    Total Stockholders' 
    Shares    Amount     Capital     Income (Loss)     Deficit     Deficit 
Balance, June 30, 2026   7,536,382,467   $753,639   $94,308,911   $104,454   $(97,255,645)  $(2,088,641)
                               
Stock based compensation - services   25,000,000   $2,500    30,000    —      —      32,500 
Stock issued for the settlement of convertible promissory notes   136,364,500   $13,636    88,283    —      —      101,919 
Foreign currency translation adjustment   —      —      —      (204)   —      (204)
Net loss   —      —      —      —      (677,029)   (677,029)
Balance, September 30, 2026   7,697,746,967   $769,775   $94,427,194   $104,250   $(97,932,674)  $(2,631,455)
                               
    Common Stock   Additional Paid-in    Accumulated Other Comprehensive    Accumulated    Total Stockholders' 
    Shares    Amount     Capital     Income (Loss)     Deficit     Deficit 
Balance, December 31, 2025   6,501,509,691   $650,152   $92,324,398   $84,379   $(95,005,002)  $(1,946,073)
                               
Stock based compensation - officers and directors   478,289,474   $47,829    909,671    —      —      957,500 
Stock based compensation - services   315,000,000   $31,500    593,500    —      —      625,000 
Stock based compensation - prepaid expense   210,000,000   $21,000    262,000    —      —      283,000 
Cancellation of shares   (77,627,224)  $(7,763)   7,763    —      —      —   
Settlement of accrued liabilities - related party   134,210,526   $13,421    241,579    —      —      255,000 
Stock issued for the settlement of convertible promissory notes   136,364,500   $13,636    88,283    —      —      101,919 
Foreign currency translation adjustment   —      —      —      19,871    —      19,871 
Net loss   —      —      —      —      (2,927,672)   (2,927,672)
Balance, September 30, 2026   7,697,746,967   $769,775   $94,427,194   $104,250   $(97,932,674)  $(2,631,455)
    Common Stock   Additional Paid-in    

 

Accumulated Other Comprehensive

    Accumulated    Total Stockholders' 
    Shares    Amount     Capital     Income (Loss)     Deficit     Deficit 
Balance, June 30, 2025   5,639,232,132   $563,924   $91,121,985   $81,916   $(95,186,898)  $(3,419,073)
                               
Stock issued for the settlement of promissory note   224,257,560    22,426    511,059    —      —      533,485 
Foreign currency translation adjustment   —      —      —      12,218    —      12,218 
Net loss   —      —      —      —      (416,336)   (416,336)
Balance, September 30, 2025   5,863,489,692   $586,350   $91,633,044   $94,134   $(95,603,234)  $(3,289,706)
    Common Stock   Additional Paid-in    

 

Accumulated Other Comprehensive

    Accumulated    Total Stockholders' 
    Shares    Amount     Capital     Income (Loss)     Deficit     Deficit 
Balance, December 31, 2024   5,469,037,729   $546,905   $90,288,032   $116,977   $(94,520,148)  $(3,568,234)
                               
Stock issued for the settlement of promissory note   224,257,560    22,426    511,059    —      —      533,485 
Stock issued for the settlement of line of credit   170,194,403    17,019    833,953    —      —      850,972 
Foreign currency translation adjustment   —      —      —      (22,843)   —      (22,843)
Net loss   —      —      —      —      (1,083,086)   (1,083,086)
Balance, September 30, 2025   5,863,489,692   $586,350   $91,633,044   $94,134   $(95,603,234)  $(3,289,706)
                               
The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

 7 
 

QUANTUM X, INC.
(FORMERLY KNOWN AS TWO HANDS CORPORATION)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

 

           
    For the nine months ended September 30, 
    2026    2025 
Cash flows from operating activities          
Net loss  $(2,927,672)  $(1,083,086)
Adjustments to reconcile net loss to cash used in operating activities          
Depreciation - property and equipment   2,273    1,491 
Amortization - right-of-use asset   —      6,451 
Bad debt   —      6,611 
Stock based compensation - officers and directors   957,500    —   
Stock based compensation - services   625,000    —   
Stock based compensation - prepaid expense   283,000      
Gain on settlement   (5,272)   —   
Write-off of advances   15,992    —   
Amortization of debt discount and interest expense   230,595    321,941 
Loss on settlement of non-redeemable convertible notes and promissory notes        17,181 
Initial derivative expense   33,804    235,220 
Change in fair value of derivative liabilities   (219,239)   (215,904)
 Change in operating assets and liabilities          
Accounts and taxes receivable   (3,919)   60,396 
Prepaid expense   (137,000)   (14,816)
Accounts payable and accrued liabilities   276,228    178,126 
Operating lease right-of-use liability   —      (6,451)
Net cash used in operating activities   (868,710)   (492,840)
           
Cash flows from investing activities          
Purchase of fixed assets   (150,000)   —   
Software development costs   (20,000)     
Deposits   (321,887)   —   
Return of deposits   104,008    —   
Net cash used in investing activities   (387,879)   —   
           
Cash flow from financing activities          
Advances   —      1,806 
Repayment of advances   —      (4,218)
Advances - related party   998,000      
Expenses paid for by related party   —      428,100 
Issuance of promissory note, net   120,000    —   
Issuance of convertible promissory note, net   265,000    75,000 
Repayment of convertible promissory notes   (274,488)   —   
Net cash provided by financing activities   1,108,512    500,688 
           
Change in foreign exchange   —      51 
           
Net change in cash   (148,077)   7,899 
           
Cash, beginning of the period   227,585    1,733 
           
Cash, end of the period  $79,508   $9,632 
           
Cash paid during the period          
Interest paid  $—     $—   
Income taxes paid  $—     $—   
           
Supplemental disclosure of non-cash investing and financing activities          
Stock issued for the settlement of line of credit  $—     $850,872 
Stock issued for the settlement of promissory notes  $—     $533,485 
Stock issued for settlement of accrued liabilities - related party  $255,000   $—   
Stock issued for the settlement of convertible promissory notes  $101,919   $—   

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

 

 8 
 

QUANTUM X, INC.

(FORMERLY KNOWN AS TWO HANDS CORPORATION)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION

 

Quantum X, Inc. (the "Company") was incorporated in the state of Delaware on April 3, 2009. On July 26, 2016, the Company changed its name from Innovative Product Opportunities Inc. to Two Hands Corporation and on September 14, 2026 the Company changed its name from Two Hands Corporation to Quantum X, Inc.

 

The Two Hands co-parenting application launched on July 2018 and the Two Hands Gone application launched In February 2019. The Company ceased work on these applications in 2021.

The Company is currently in the process of shifting its focus to becoming a technology company, specifically in the artificial intelligence and quantum computing spaces. The Company’s AI strategy is to address the needs of three distinct economies, each of which requires a different solution: personal AI, enterprise automation, and compute frontier through a portfolio of three products: Pegasus, Scalova, and EntangleX. 

On June 30, 2026, pursuant to stockholder consent, our Board of Directors authorized an amendment (the “Amendment”) to our Certificate of Incorporation, as amended, to change the name of the Corporation from Two Hands Corporation to Quantum X, Inc. The Company filed the Amendment with the Delaware Secretary of State on July 8, 2026. On September 11, 2026, FINRA announced the name change, together with a change of the Company’s trading symbol from “TWOH” to “QUTX”, on its Daily List. The name change and the symbol change became effective on September 14, 2026. The Company’s common stock now trades under the symbol “QUTX.”

 

On July 7, 2026, the Company voluntarily delisting its common shares from the Canadian Securities Exchange (the "CSE").  The Company’s common shares are no longer listed or posted for trading on the CSE. The Company’s common stock continues to be quoted on the OTC Markets under the symbol “QUTX”. 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

BASIS OF PRESENTATION

 

The accompanying condensed consolidated financial statements of Quantum X, Inc. have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission requirements for interim financial statements. Therefore, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The financial statements should be read in conjunction with the annual financial statements for the year ended December 31, 2025 of Quantum X, Inc. in our Form 10-K filed on April 10, 2026.

 

The interim financial statements present the balance sheets, statements of operations, stockholders’ deficit and cash flows of Quantum X, Inc. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States.

 

The interim financial information is unaudited. In the opinion of management, all adjustments necessary to present fairly the financial position as of September 30, 2026 and the results of operations and cash flows presented herein have been included in the financial statements. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results of operations for the full year.

 

GOING CONCERN

 

The Company's financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern. This contemplates the realization of assets and the liquidation of liabilities in the normal course of business. During the nine months ended September 30, 2026, the Company incurred a net loss of $2,927,672 and used cash in operating activities of $868,710, and on September 30, 2026, had stockholders’ deficit of $2,631,455 and an accumulated deficit of $97,932,674. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date that the financial statements are issued. The Company will be dependent upon the raising of additional capital through placement of its common stock in order to implement its business plan. There can be no assurance that the Company will be successful in this situation. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classifications of liabilities that might result from this uncertainty. We are currently funding our operations by way of cash advances from our Chief Executive Officer, note holders, shareholders and others; however, we do not have any oral or written agreements with them or others to loan or advance funds to us. There can be no assurances that we will be able to receive loans or advances from them or other persons in the future.

 

 9 
 

 

PRINCIPLES OF CONSOLIDATION

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Two Hands Canada Corporation and Meridian Capital Management Inc. All intercompany transactions and balances have been eliminated in consolidation.

 

USE OF ESTIMATES AND ASSUMPTIONS

 

Preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

 

CASH AND CASH EQUIVALENTS

 

For the purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.

 

ACCOUNTS RECEIVABLE

 

Trade accounts receivable is recorded at the invoiced amount and do not bear interest. The Company grants credit to its customers with defined payment terms, performs ongoing evaluations of the credit worthiness of its customers and generally does not require collateral. Accounts receivables are carried at their outstanding principal amounts, less an anticipated amount for discounts and an allowance for expected credit losses, which management believes is sufficient to cover potential credit losses based on historical experience and periodic evaluation of the financial condition of the Company's customers. Estimated credit losses consider relevant information about past events, current conditions and reasonable and supporting forecasts that affect the collectability of financial assets.

 

The allowance for doubtful accounts on September 30, 2026 and December 31, 2025 is $139,043 and $144,184, respectively. As of September 30, 2026 and December 31, 2025, net accounts receivable is $0.

 

PROPERTY AND EQUIPMENT

 

Property and equipment is stated at cost, less accumulated depreciation and amortization. Expenditures for maintenance and repairs are charged to expense when incurred, while renewals and betterments that materially extend the life of an asset are capitalized.

 

The costs of assets sold, retired, or otherwise disposed of, and the related allowance for depreciation, are eliminated from the accounts, and any resulting gain or loss is recognized in the results from operations. Depreciation is provided over the estimated useful lives of the assets, which are as follows:

 

Graphics Processing Unit (GPU) straight line over 5 years

Computer equipment 50% declining balance over a three year useful life. In the year of acquisition, one half the normal rate of depreciation is provided

 

REVENUE RECOGNITION

 

In accordance with Accounting Standards Codification (“ASC”) 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which we expect to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which we determine revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which we expect to be entitled in exchange for those goods or services. ASC 606 requires us to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, we satisfy the performance obligation.

 

DEBT DISCOUNT AND DEBT ISSUANCE COSTS

 

Debt discounts and debt issuance costs incurred in connection with the issuance of convertible notes are capitalized and amortized to interest expense based on the related debt agreements using the effective interest rate method. Unamortized discounts are netted against convertible notes.

 10 
 

 

DERIVATIVE LIABILITIES

 

The Company evaluates the embedded features of its financial instruments, including convertible notes payable, in accordance with ASC 480, “Distinguishing Liabilities from Equity,” and ASC 815, “Derivatives and Hedging.” Certain conversion options and certain contingent features are required to be bifurcated from their host instrument and accounted for separately as derivative financial instruments when applicable criteria are met. The Company applies significant judgment to identify and evaluate complex terms and conditions of its financial instruments to determine whether such instruments are derivatives or contain features that qualify as embedded derivatives.

 

Bifurcated embedded derivatives are recognized at fair value at issuance, with the fair value recorded as a derivative liability and a corresponding debt discount limited to the proceeds received; any excess of the derivative’s fair value over the proceeds is recognized in the condensed consolidated statements of operations at issuance. Debt discounts are amortized to interest expense over the term of the related note. Bifurcated embedded derivatives are remeasured to fair value each reporting period, with changes in fair value recognized in the condensed consolidated statements of operations. Upon conversion, repayment, or extinguishment of the host instrument, the related derivative liability is remeasured to fair value with the change recognized in earnings and is then derecognized as part of the settlement or extinguishment accounting.

 

The fair value of bifurcated embedded derivatives is estimated using a Monte Carlo simulation model incorporating significant unobservable inputs, and such measurements are classified within Level 3 of the fair value hierarchy.

 

INCOME TAXES

 

The Company accounts for income taxes in accordance with ASC") 740, Income Taxes. Under the assets and liability method of ASC 740, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

 

NET LOSS PER SHARE

 

Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of common shares outstanding for the period increased to include the number of additional common shares that would have been outstanding if potentially dilutive securities had been issued. Dilutive net loss per share for common stock is calculated utilizing the if-converted method which assumes the conversion non-redeemable convertible notes and the line of credit. On September 30, 2026, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible promissory notes of 2,013,730,387 shares as their effect would have been anti-dilutive. On September 30, 2025, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible notes of 1,301,143,126 shares as their effect would have been anti-dilutive.

 

FOREIGN CURRENCY TRANSLATION

 

The consolidated financial statements are presented in United States dollars. The functional currency of the consolidated entities is determined by evaluating the economic environment of each entity. The functional currency of Quantum X, Inc. is the United States dollar. Foreign exchange translation adjustments are reported as gains or losses resulting from foreign currency transactions and are included in the results of operations.

 

Two Hands Canada Corporation maintains its accounts in the Canadian dollar. Assets and liabilities are translated to United States dollars at period-end exchange rates. Income and expenses are translated at the average exchange rate during the period. Foreign currency transaction adjustments are reported as other comprehensive income, a component of equity in the consolidated statements of stockholders’ deficit.

 

STOCK-BASED COMPENSATION

 

The Company accounts for stock incentive awards issued to employees and non-employees in accordance with ASC 718, “Compensation—Stock Compensation.” Accordingly, stock-based compensation is measured at the grant date, based on the fair value of the award. Stock-based awards to employees are recognized as an expense over the requisite service period, or upon the occurrence of certain vesting events. Additionally, stock-based awards to non-employees are expensed over the period in which the related services are rendered.

 11 
 

FAIR VALUE OF FINANCIAL INSTRUMENTS

 

ASC 820, “Fair Value Measurements,” defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.

 

Included in the ASC 820 framework is a three level valuation inputs hierarchy with Level 1 being inputs and transactions that can be effectively fully observed by market participants spanning to Level 3 where estimates are unobservable by market participants outside of the Company and must be estimated using assumptions developed by the Company. The Company discloses the lowest level input significant to each category of asset or liability valued within the scope of ASC 820 and the valuation method as exchange, income or use. The Company uses inputs which are as observable as possible and the methods most applicable to the specific situation of each company or valued item.

 

The Company’s financial instruments such as cash, accounts payable and accrued liabilities, non-redeemable convertible notes, notes payable and due to related parties are reported at cost, which approximates fair value due to the short-term nature of these financial instruments.

 

The fair value of financial instruments measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025 consisted of the following:

 

         
   September 30, 2026
   Level 1  Level 2  Level 3
Description  $  $  $
Derivative liabilities   —      —      213,500 

  

          
   December 31, 2025
   Level 1  Level 2  Level 3
Description  $  $  $
Derivative liabilities   —      —      395,464 

 

The following table presents changes in the Company’s Level 3 derivative liabilities measured at fair value on a recurring basis:

 

     
   Amount
Derivative Liabilities     
Balance as of December 31, 2025  $395,464 
Initial fair value of embedded derivative liability upon issuance of convertible note (limited to proceeds)   301,900 
Initial derivative expense upon issuance of convertible note (in excess of proceeds)   33,804 
Extinguishment of derivative liabilities upon repayment of convertible notes   (298,429)
Gain on change in fair value of derivative liabilities   (219,239)
Balance as of September 30, 2026  $213,500 

 

Balance as of December 31, 2024  $0 
Initial fair value of embedded derivative liability upon issuance of convertible note (limited to proceeds)   75,000 
Initial derivative expense upon issuance of convertible note (in excess of proceeds)   235,220 
Gain on change in fair value of derivative liabilities   (215,904)
Balance as of September 30, 2025  $94,316 

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

Recently Adopted

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-04, “Debt—Debt with Conversion and Other Options,” which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The new guidance is effective for annual reporting periods beginning after December 15, 2025 and can be applied either prospectively or retrospectively. The adoption of ASU 2024-04 did not have a material impact on the Company’s condensed consolidated financial statements.

 12 
 

In July 2025, the FASB issued ASU 2025-05, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,” which introduces a practical expedient for the application of the current expected credit loss model to current accounts receivable and contract assets. The amendment is effective for interim and annual periods beginning after December 15, 2025, with early adoption permitted. This amendment is to be applied on a prospective basis. The adoption of ASU 2025-05 did not have a material impact on the Company’s condensed consolidated financial statements.

 

Recently Issued — Not Yet Adopted

 

In November 2024, the FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization included in each relevant expense caption presented on the statement of operations. The standard also requires a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, as well as the total amount of selling expenses and an entity’s definition of selling expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods within annual periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.

 

In October 2023, the FASB issued ASU 2023-06, “Disclosure Improvements — Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” The ASU amends the disclosure or presentation requirements related to various subtopics in the FASB ASC. The ASU was issued in response to the SEC’s August 2018 final amendments in Release No. 33-10532, Disclosure Update and Simplification that updated and simplified disclosure requirements that the SEC believed were duplicative, overlapping, or outdated. The guidance in ASU 2023-06 is intended to align GAAP requirements with those of the SEC and to facilitate the application of GAAP for all entities. The amendments introduced by ASU 2023-06 are effective if the SEC removes the related disclosure or presentation requirement from its existing regulations by June 30, 2027. If, by June 30, 2027, the SEC has not removed the applicable requirements from its existing regulations, the pending content of the associated amendment will be removed from the ASC and will not become effective for any entities. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.

 

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow-Scope Improvements.” ASU 2025-11 clarifies and improves existing interim reporting guidance by consolidating disclosure requirements within Topic 270 and introducing a disclosure principle requiring entities to disclose events and changes occurring after the most recent annual reporting period that are expected to have a material effect on the entity’s financial condition or results of operations. The ASU does not introduce significant changes to recognition or measurement guidance. The amendments in ASU 2025-11 are effective for interim reporting periods within fiscal years beginning after December 15, 2027, with early adoption permitted. ASU 2025-11 allows for either a prospective or retrospective approach on adoption. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.

 

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

 

NOTE 3 – PROPERTY AND EQUIPMENT

                    
   Cost  Accumulated Depreciation  September 30,
2026
Net Book Value
  December 31,
2025
Net Book Value
Graphics Processing Unit (GPU)  $150,000   $1,250   $148,750   $—   
Computer   21,428    18,189    3,239    4,392 
   $171,428   $19,439   $151,989   $4,392 

 

Depreciation expense for nine months ended September 30, 2026 and 2025 was $2,273 and $1,490, respectively. The Graphics Processing Unit (GPU) is located and operates in Nepal.

 

 13 
 

NOTE 4 – CAPITALIZED SOFTWARE DEVELOPMENT COSTS

 

The Company capitalizes costs incurred to develop software for internal use, including software that will be used to provide a hosted service to customers who will not take possession of the software, in accordance with ASC 350-40, Intangibles—Goodwill and Other—Internal-Use Software. Costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when the preliminary project stage is complete, management with the relevant authority has authorized and committed to funding the project, and it is probable that the project will be completed and the software will be used to perform the function intended. Costs incurred during the post-implementation stage, including training and routine maintenance, are expensed as incurred. Costs of upgrades and enhancements are capitalized only when it is probable that the expenditures will result in additional functionality.

 

In August 2026, the Company concluded that the foregoing criteria had been met with respect to Scalova, its enterprise automation product, and began capitalizing application development stage costs incurred after that date. The Company capitalized $20,000 of such costs during the three months ended September 30, 2026. Capitalized software development costs were $20,000 and $0, at September 30, 2026 and December 31, 2025, respectively, and are presented as a separate non-current asset on the condensed consolidated balance sheets. The entire capitalized amount was paid to the Company’s Head of Strategy under the product services agreement described in Note 8 – Related Party Transactions.

 

The Scalova software was not ready for its intended use at September 30, 2026 and, accordingly, no amortization has been recorded. Amortization will commence when the software is ready for its intended use and will be recognized on a straight-line basis over the estimated useful life of the software.

 

Capitalized software development costs are reviewed for impairment in accordance with ASC 360-10 whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. No impairment charge was recorded during the three or nine months ended September 30, 2026.

 

Costs incurred during the three and nine months ended September 30, 2026 with respect to the Company’s Pegasus and EntangleX products did not meet the criteria for capitalization and were expensed as incurred within general and administrative expense.

 

NOTE 5 – NON-REDEEMABLE CONVERTIBLE NOTE, NET – RELATED PARTY

 

On September 13, 2018, the Company entered into a Side Letter Agreement (“Original Note”) with a non-related investor, Jordan Turk, to amend and add certain terms to unsecured, non-interest bearing, due on demand notes payable totaling $40,000 issued by the Company during the period of July 10, 2018 to September 13, 2018. The issue price of the Note is $40,000 with a face value of $48,000 and the Note has an original maturity date of December 31, 2018 which is subject to automatic annual renewal. On June 29, 2021, the Company and Jordan Turk entered into an Agreement to change the original maturity date of the Note to December 31, 2025. At the option of the Company, the Company may convert principal and interest at a fixed conversion price of $0.0001 per share of the Company’s common stock. The Note allows the lender to secure a portion of the Company assets up to 200% of the face value of the Note. If the Note is not paid on December 31 each year, the outstanding face amount of the Note increases by 20% on January 1 the following year.

 

On December 30, 2024, Jordan Turk and the Company agreed to exchange $43,328 of principal and interest of Original Note for a New Promissory Note with a carrying value of $71,993 resulting in a loss of extinguishment of $28,665.

 

Also, on December 30, 2024, Jordan Turk entered into an agreement to assign the remaining outstanding principal and interest of the Original Note with a carrying value of $100,000 to Emil Assentato, the Chief Executive Officer of the Company.

 

The consolidated statement of operations includes amortization of debt discount of $17,951 and $14,959 for the nine months ended September 30, 2026 and 2025, respectively, due to the 20% increase in face value on January 1 each year. On September 30, 2026 and December 31, 2025, the carrying amount of the Note is $137,951 (face value of $144,000 less $6,049 unamortized discount) and $120,000 (face value of $120,000 less $0 unamortized discount), respectively.

 

NOTE 6 – NOTES PAYABLE

 

As of September 30, 2026 and December 31, 2025, notes payable due to Piero Manzini and Nadav Elituv, the former CEO of the Company, totaling $114,736 and $118,978, respectively, were outstanding. The balances are non-interest bearing, unsecured and have no specified terms of repayment.

 

NOTE 7 – CONVERTIBLE PROMISSORY NOTES, NET

 

Vanquish Funding Group, Inc.

 

On November 13, 2025, the Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. (“Holder”) relating to the issuance and sale of a Convertible Note (the “Note”) with an original principal amount of $115,000 less original issue discount of $15,000 and transaction costs of $7,000 bearing a 10% annual interest rate and maturing August 15, 2026 for $93,000 in cash. After 180 days after the issue date, the Note together with any unpaid accrued interest is convertible into shares of common stock of the Company at the Holder’s option at a variable conversion price calculated at 75% of the lowest closing bid price during the 10 trading days prior to the conversion date. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the holder’s deposit fees associated with the conversion. The Company may prepay the Note in cash, if prepaid within 90 days of date of issue, at 115% of the outstanding principal amount plus accrued and unpaid interest; between 91 and 150 days, at 120%; and between 151 and 180 days, at 125%. On May 14, 2026, the Company fully settled the Note at amortized cost of $21,090 and along with the related derivative liability (Note 8) at a fair value of $167,597 with a payment in cash of $150,800 resulting in a gain on extinguishment of debt of $37,887. On September 30, 2026 and December 31, 2025, the Note was recorded at amortized cost of $0 and $1,849 (comprised of principal of $115,000 plus accrued interest of $1,512 less debt discount of $114,663), respectively. The Note is paid in full.

 

 14 
 

On December 2, 2025, the Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. (“Holder”) relating to the issuance and sale of a Convertible Note (the “Note”) with an original principal amount of $94,300 less original issue discount of $12,300 and transaction costs of $7,000 bearing a 10% annual interest rate and maturing September 15, 2026 for $75,000 in cash. After 180 days after the issue date, the Note together with any unpaid accrued interest is convertible into shares of common stock of the Company at the Holder’s option at a variable conversion price calculated at 75% of the lowest closing bid price during the 10 trading days prior to the conversion date. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the holder’s deposit fees associated with the conversion. The Company may prepay the Note in cash, if prepaid within 90 days of date of issue, at 115% of the original principal amount plus interest, between 91 days and 150 days at 120% of the original principal amount plus interest and between 151 days and 180 days at 115% of the outstanding principal amount plus accrued and unpaid interest; between 91 and 150 days, at 120%; and between 151 and 180 days, at 125%. On June 1, 2026, the Company fully settled the Note at amortized cost of $18,941 and along with the related derivative liability (Note 8) at a fair value of $72,132 with a payment in cash of $123,688 resulting in a loss on extinguishment of debt of $32,615. On September 30, 2026 and December 31, 2025, the Note was recorded at amortized cost of $0 and $750 (comprised of principal of $94,300 plus accrued interest of $749 less debt discount of $94,299), respectively. The Note is paid in full.

 

On January 16, 2026, the Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. (“Holder”) relating to the issuance and sale of a Convertible Note (the “Note”) with an original principal amount of $100,050 less original issue discount of $13,050 and transaction costs of $7,000 bearing a 10% annual interest rate and maturing October 15, 2026 for $80,000 in cash. After 180 days after the issue date, the Note together with any unpaid accrued interest is convertible into shares of common stock of the Company at the Holder’s option at a variable conversion price calculated at 75% of the lowest closing bid price during the 10 trading days prior to the conversion date. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the holder’s deposit fees associated with the conversion. The Company may prepay the Note in cash, if prepaid within 90 days of date of issue, at 115% of the outstanding principal amount plus accrued and unpaid interest; between 91 and 150 days, at 120%; and between 151 and 180 days, at 125%. In accordance with the contractual terms of the Note, from July 20, 2026 to August 6, 2026, the Holder converted 136,364,500 shares of common stock of the Company to settle principal and interest of $112,765 ($100,050 of principal and $12,715 of interest). The conversions resulted in the settlement of derivative liabilities of $58,700 (Note 8). On December 31, 2026 and 2025, the Note was recorded at amortized cost of $0 and $0, respectively. The Note is paid in full.

 

On July 6, 2026, the Company entered into a Securities Purchase Agreement with the Holder relating to the issuance and sale of a convertible promissory note (the “Note”) with an original principal amount of $151,800 less original issue discount of $19,800 and transaction costs of $7,000 bearing a 10% annual interest rate and maturing July 6, 2027 for $125,000 in cash. Beginning 180 days after the issue date, the Note, together with any unpaid accrued interest, is convertible into shares of common stock of the Company at the Holder’s option at a variable conversion price calculated as 75% of the average of the three lowest closing bid prices during the ten trading days prior to the conversion date. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the holder’s deposit fees associated with the conversion. In the event of default, the Note shall become immediately due and payable at an amount equal to 150% times the sum of outstanding principal, accrued and unpaid interest, and Default Interest at 22% per annum. The Company may prepay the Note in cash within 180 days of the issue date, at 125% of the outstanding principal amount plus accrued and unpaid interest; no prepayment is permitted after 180 days from the issue date. On September 30, 2026 the Note was recorded at amortized cost of $52,884 (comprised of principal of $151,800 plus accrued interest of $3,577 less debt discount of $102,493).

 

On September 15, 2026, the Company entered into a Securities Purchase Agreement with the Holder relating to the issuance and sale of a convertible promissory note (the “Note”) with an original principal amount of $77,050 less original issue discount of $10,050 and transaction costs of $7,000 bearing a 10% annual interest rate and maturing September 15, 2027 for $60,000 in cash. Beginning 180 days after the issue date, the Note, together with any unpaid accrued interest, is convertible into shares of common stock of the Company at the Holder’s option at a variable conversion price calculated as 75% of the average of the three lowest closing bid prices during the ten trading days prior to the conversion date. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the holder’s deposit fees associated with the conversion. In the event of default, the Note shall become immediately due and payable at an amount equal to 150% times the sum of outstanding principal, accrued and unpaid interest, and Default Interest at 22% per annum. The Company may prepay the Note in cash within 180 days of the issue date, at 125% of the outstanding principal amount plus accrued and unpaid interest; no prepayment is permitted after 180 days from the issue date. On September 30, 2026 the Note was recorded at amortized cost of $15,689 (comprised of principal of $77,050 plus accrued interest of $316 less debt discount of $61,677).

 

Vanquish Funding Group, Inc. – Modified Promissory Note

 

In July 17, 2026, the Company and the Holder amended the promissory note ( the “New Note”) issued May 20, 2026 to, among other things, (i) convert the note from an instrument convertible only upon an Event of Default into a note that is convertible into shares of common stock of the borrower at the Holder’s election on the terms set forth below (ii) provide for a variable conversion price consistent with the terms of the convertible promissory note issued by the borrower to the Holder dated July 6, 2026 (that is, a variable conversion price calculated as 75% of the average of the three lowest closing bid prices during the ten trading days prior to the conversion date) (iii) replace the scheduled payments with a single payment of principal and interest at maturity and (iv) replace the tiered prepayment discount schedule with a flat prepayment percentage consistent with the terms of the July 6, 2026 note (that is, the Company may prepay the Note in cash, within 180 days of the issue date, at 125% of the outstanding principal amount plus accrued and unpaid interest; no prepayment is permitted after 180 days from the issue date).

 

 15 
 

The original terms of the May 20, 2026 before the amendment on July 17,2026 is as follows:

 

On May 20, 2026, the Company entered into a Securities Purchase Agreement with Vanquish Funding Group, Inc. (“Holder”) relating to the issuance and sale of a promissory note (the “Note”) with an original principal amount of $146,050 less original issue discount of $19,050 and transaction costs of $7,000 with a one-time interest charge of 12% ($17,526) applied on the issuance date, and maturing March 30, 2027, for $120,000 in cash. The Note principal and accrued interest is payable in cash payments of $81,788, $20,447, $20,447, $20,447 and $20,447 on November 30, 2026, December 30, 2026, January 30, 2027, February 28, 2027 and March 30, 2027, respectively. In the event of default, the Note shall become immediately due and payable at an amount equal to 150% times the sum of (a) outstanding principal, (b) accrued and unpaid interest, and (c) default interest at 22% per annum (the “Default Amount”). Following an Event of Default and, at the earliest, 180 days after issuance, the Note is convertible into shares of the Company’s common stock at the Holder’s option at a conversion price equal to 65% of the lowest closing bid price during the ten trading days prior to the conversion date. In addition, if the Company fails to pay the Default Amount within five business days of written notice, the Holder may convert the balance owed, including the Default Amount, at the same conversion price. Additionally, the Holder of the Note is entitled to deduct $1,500 from the conversion amount in each note conversion to cover the Holder's deposit fees associated with the conversion. Notwithstanding anything contrary contained in the Note, the Company may prepay the Note in cash. If prepaid within 60 days of the date of issue, at 95% of the outstanding principal amount plus accrued and unpaid interest; between 61 and 90 days, at 96%; between 91 and 150 days, at 97%; and between 151 and 180 days, at 98%. The Note’s conversion feature is exercisable only following an Event of Default and, at the earliest, 180 days after issuance. The Company evaluated the embedded features of the Note under ASC 815-15 and concluded that any embedded derivative associated with the default-contingent conversion feature had no material value at issuance or at July 17, 2026 (prior to modification), as no Event of Default had occurred or was pending and the conversion right was not exercisable during the period.

 

The amendment to the promissory note on July 17, 2026 is accounted for as a modification on a prospective basis with no gain or loss recorded. The Company evaluated the embedded conversion feature of the New Note for bifurcation under ASC 815-15 and, as such, recorded a derivative liability on July 17, 2026 with a fair value of $86,900. The increase in the fair of derivative liabilities of $86,900 was offset by an increase in debt discount of $86,900. The increase in debt discount is accounted for using the effective interest rate method.

 

On September 30, 2026 the New Note was recorded at amortized cost of $67,375 (comprised of principal of $150,774 plus accrued interest of $3,751 less debt discount of $87,150).

 

NOTE 8 - DERIVATIVE LIABILITY

 

The Convertible Promissory Notes with Vanquish Funding Group, Inc. with issue and modification dates of November 13, 2025, December 2, 2025, January 16, 2026, July 6, 2026, July 17, 2026 and September 15, 2026 are accounted for under ASC 815.  Because the conversion price varies with the market price of the Company’s common stock, the conversion feature is not considered indexed to the Company’s own stock and does not qualify for the scope exception in ASC 815-40; accordingly, the conversion feature is bifurcated from the debt host and accounted for as a derivative liability. The Company’s derivative liabilities have been measured at fair value using the Monte Carlo simulation model starting June 30, 2026 and binomial model at all other periods (the “fair value models”). The Company changed its valuation technique to a Monte Carlo simulation model on June 30, 2026 to better reflect the path-dependent conversion price mechanics of the notes; the change is accounted for prospectively as a change in accounting estimate.

 

The inputs into the fair value models are as follows:

 

           
  September 30, 2026 September 15, 2026 July 17, 2027 July 6, 2026 June 30, 2026 March 31, 2026
Stock price $0.0009 $0.0014 $0.0015 $0.0017 $0.0012 $0.0012
Conversion price $0.0007 $0.0008 $0.0012 $0.0009 $0.0009 $0.0008
Risk-free rate 4.33% - 4.54% 4.39% 4.01% 3.95% 3.92% 3.70%
Expected volatility 139% - 168% 169% 155% 173% 148.7% 154% – 193%
Dividend yield 0% 0% 0% 0% 0% 0%
Expected life 0.37 – 0.66 years 0.69 years 0.48 years 0.69 years 0.29 years 0.38 – 0.54 years

  

 16 
 

   January 16,
2026
  December 31,
2025
  December 2,
2025
  November 13,
2025
Stock price  $0.0017   $0.0016   $0.0011   $0.0024 
Conversion price  $0.0011   $0.0007   $0.0008   $0.0013 
Risk-free rate   3.70%   4.29%   3.90%   3.90%
Expected volatility   234%   227%   258%   256%
Dividend yield   0%   0%   0%   0%
Expected life   0.75 years    0.62 – 0.71 years    0.79 years    0.75 years 

 

NOTE 9 – RELATED PARTY TRANSACTIONS

 

Notes payable – related party

 

On September 30, 2026 and December 31, 2025, $1,959,777 (comprising of $1,851,100 of advances and $108,677 of interest) and $882,632 (comprising of $853,100 of advances and $29,532 of interest), respectively was due to Emil Assentato, the Company's Chief Executive Officer. During nine months ended September 30, 2026, the Company issued total advances for $998,000 comprising $998,000 for cash received and $0 of expenses paid on behalf of the Company. This note payable – related party earns interest at 8% per annum, is unsecured and is due on demand.

 

Employment Agreements

 

During the nine months ended September 30, 2026 and 2025, compensation expenses of $1,301,000 (comprising stock-based compensation of $957,500 and cash compensation of $343,500) and $212,917, respectively, was incurred for the Chief Executive Officer, Chief Financial Officer, Head of Strategy and a Director.

 

Software Development Agreement

 

On May 1, 2026, the Company entered into an agreement with Ujjwal Roy, the Head of Strategy of the Company, under which Mr. Roy agreed to (a) complete the build-out of the user interface for EntangleX and (b) provide ongoing maintenance, operations, marketing, sales and engineering services (“monthly operating costs”) for EntangleX and Scalova. The Company committed to $250,000 in expenditures for the EntangleX build-out and to estimated monthly operating costs of approximately $35,000 ($15,000 for EntangleX and $20,000 for Scalova), payable commencing on the launch date of each respective product. The estimated monthly amounts may be adjusted by mutual agreement of the parties as actual costs are determined.

During the three and nine months ended September 30, 2026, the Company paid $140,000 and $290,000, respectively, to Mr. Roy under this agreement, comprising $70,000 and $150,000 applied against the EntangleX build-out commitment and $70,000 and $140,000 of monthly operating costs (see also below). No amounts were paid under this agreement during the three and nine months ended September 30, 2025, as the agreement was entered into on May 1, 2026.

The Company accounts for the costs of developing these products in accordance with ASC 350-40, as the software will be hosted on the Company’s servers and customers will not take possession of the software. Of the $290,000 paid during the nine months ended September 30, 2026, the Company capitalized $20,000 of Scalova costs incurred after August 2026, the date on which the Company concluded that the capitalization criteria of ASC 350-40 had been met with respect to Scalova; those costs are presented in capitalized software development costs on the condensed consolidated balance sheets (see Note 4). The remaining $270,000, comprising $150,000 of EntangleX build-out costs and $120,000 of monthly operating costs, was expensed as incurred and is included in general and administrative expense on the condensed consolidated statements of operations and comprehensive income (loss), as those costs were incurred before the capitalization criteria had been met for the respective product.

At September 30, 2026, $100,000 of the EntangleX build-out commitment remained unpaid and is included in accrued liabilities – related party on the condensed consolidated balance sheets. The EntangleX build-out was not complete at September 30, 2026.

Settlement of Accrued Liabilities

 

During the nine months ended September 30, 2026, the Company issued 134,210,526 shares of the Company’s common stock with a fair value of $255,000 ($0.0019 per share) pursuant to the Company’s 2026 Stock Incentive Plan to settle accrued liabilities – related party due to Emil Assentato, the Chief Executive Officer of the Company.

 

NOTE 10 - STOCKHOLDERS' EQUITY

 

The Company is authorized to issue an aggregate of 12,000,000,000 common shares with a par value of $0.0001 per share and 1,000,000 shares of preferred stock with a par value of $0.001 per share.

 

Preferred Stock

 

On August 6, 2013, the Company filed a Certificate of Designation with the Delaware Secretary of State thereby designating two hundred thousand (200,000) shares as Series A Convertible Preferred Stock, par value $0.01 per share (“Series A Stock”). Each share of Series A Stock is convertible into one thousand (1,000) shares of common stock of the Company. On April 21, 2022, the Company amended its articles to amend the terms of its Series A Convertible Preferred Stock to become non-voting shares. Previously Series A Stock were entitled to the number of votes equal to the aggregate number of shares of common stock into which the Holder’s share of Series A Stock is convertible, multiplied by one hundred (100).

 

 17 
 

On December 12, 2019, the Company filed a Certificate of Designation with the Delaware Secretary of State thereby designating one hundred thousand (100,000) shares as Series B Convertible Preferred Stock, par value $0.01 per share (“Series B Stock”). After a one year holding period, each share of Series B Stock is convertible into one thousand (1,000) shares of common stock of the Company. Series B Stock is non-voting.

 

On October 7, 2020, the Company filed a Certificate of Designation with the Delaware Secretary of State thereby designating five thousand (5,000) shares as Series C Convertible Preferred Stock, par value $0.001 per share (“Series C Stock”). Each share of Series C Stock (i) has a liquidation value of $100, subject to various anti-dilution protections (ii) is convertible into shares of common stock of the Company nine months after the date of issuance at a price of $0.25 per share effective June 30, 2022, subject to various anti-dilution protections (iii) on conversion will receive an aggregate number of shares of common stock as is determined by dividing the liquidation value by the conversion price. Series C Stock are non-voting. On June 24, 2021, the board of directors approved the increase in the number of designated shares of Series C Convertible Preferred Stock from 5,000 to 30,000 and reduction of the conversion price from $0.0035 per share to $0.002 per share. On April 27, 2022, a 1 for 1,000 reverse stock split of the Company’s common stock took effect which increased the conversion rate from $0.002 per share to $2.00 per share. On June 30, 2022, the Company made an amendment to the Certificate of Designation of its Series C Stock which lowered the fixed conversion price from $2.00 per share to $0.25 per share.

 

On September 1, 2021, the Company filed a Certificate of Designation with the Delaware Secretary of State thereby designating two hundred thousand (200,000) shares as Series D Convertible Preferred Stock, par value $0.001 per share (“Series D Stock”). Each share of Series D Stock is convertible into one hundred (100) shares of common stock of the Company six months after the date of issuance. Series D Stock are non-voting.

  

On October 4, 2022, the Company filed a Certificate of Designation with the Delaware Secretary of State that had the effect of designating 300,000 shares of preferred stock as Series E Convertible Preferred Stock (“Series E Stock”). Series E Stock are non-voting, have a par value of $0.0001 per share and have a stated value of $1.00 per share. Each share of Series E Stock carries an annual cumulative dividend of 10% of the stated value. The Company may redeem Series E Stock in cash, if redeemed within 60 days of issuance date, at 110% of the stated value plus accrued unpaid dividends and between 61 days and 180 days at 115% of the stated value plus unpaid accrued dividends. After 180 days of the issuance date, the Company does not have the right to redeem Series E Stock. After 180 days after the issue date, Series E Stock at the stated value together with any unpaid accrued dividends are convertible into shares of common stock of the Company at the Holder’s option at a variable conversion price calculated at 75% of the market price defined as the lowest three average trading price during the ten trading day period ending on the latest trading day prior to the conversion date. After 18 months following the issuance date, the Company must redeem for cash Series E Stock at its stated value plus any accrued unpaid dividends and the default adjustment, if any.

 

Common Stock

 

During the nine months ended September 30, 2026, the Company issued an aggregate of 478,289,474 shares of the Company’s common stock with a fair value of $957,500 ($0.002 per share) pursuant to the Company’s 2026 Stock Incentive Plan. The shares were issued to certain officers, directors and consultants of the Company in consideration for services rendered pursuant to the terms of the Plan and applicable award agreements.

 

During the nine months ended September 30, 2026, the Company issued an aggregate of 315,000,000 shares of the Company’s common stock with a fair value of $625,000 ($0.002 per share) for services pursuant to the Company’s 2026 Stock Incentive Plan.

 

During the nine months ended September 30, 2026, the Company issued 210,000,000 shares of common stock of the Company for consulting and corporate advisory services with a fair value of $283,000 ($0.0013 per share) which was included in prepaid expenses. Prepaid expenses are amortized over periods from nine months to twelve months.

 

During the nine months ended September 30, 2026, the Company returned to treasury and cancelled 77,627,224 shares of common stock.

 

During the nine months ended September 30, 2026, the Company issued 134,210,526 shares of the Company’s common stock with a fair value of $255,000 ($0.0019 per share) pursuant to the Company’s 2026 Stock Incentive Plan to settle accrued liabilities – related party due to Emil Assentato, the Chief Executive Officer of the Company.

 

 18 
 

During the nine months ended September 30, 2026, the Company issued 136,364,500 shares of the Company’s common stock Company to settle principal and interest of $112,765 ($100,050 of principal and $12,715). The conversions resulted in the settlement of derivative liabilities of $58,700 (Note 8).

 

2026 Stock Incentive Plan

 

On March 6, 2026, the Board of Directors approved the 2026 Stock Incentive Plan (the “2026 Plan”) to attract and retain the best available personnel, to provide additional incentive to employees, directors and consultants, and to promote the success of the Company's business. Pursuant to the 2026 Plan, the Board may grant incentive stock options, non-qualified stock options, stock appreciation rights, restricted shares and restricted share units. to eligible persons. The maximum aggregate number of shares of common stock with respect to which awards granted under the Plan shall not exceed 1,200,000,000. At September 30, 2026, there are 272,500,000 shares of common stock available under the 2026 Plan.

 

NOTE 11 – SEGMENT REPORTING

 

Operating segments are defined as components of an entity for which separate discrete financial information is available and is regularly evaluated by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company has one reportable segment: the development of artificial intelligence and quantum computing software products. The Company’s CODM is Emil Assentato, President, Chief Executive Officer and Director.

 

The CODM assesses the performance of the segment and decides how to allocate resources based on consolidated general and administrative expenses and consolidated net loss, which the CODM reviews against prior quarters and against the Company’s operating budget. Discrete financial information is not prepared or reviewed below the consolidated level, and accordingly the measure of segment profit or loss is consolidated net loss as reported in the condensed consolidated statements of operations and comprehensive income (loss).

 

The Company generated no revenue during the three and nine months ended September 30, 2026 and 2025, has incurred losses, and expects to continue to incur losses as it develops its Pegasus, Scalova, and EntangleX products, none of which has reached a marketable stage. The CODM uses cash forecasts, together with the expected timing and cost of completing each product under development, in deciding how to allocate the Company’s available funds among those products and in determining the timing and amount of advances from the Chief Executive Officer and other financings. Total segment assets are the same as total consolidated assets.

 

NOTE 12 – COMMITMENTS

 

Software Development Agreement

On May 1, 2026, the Company entered into a contract with Ujjwal Roy, the Head of Strategy of the Company, to (a) complete the build-out of the user face for EntangleX and (b) provide ongoing maintenance, operations, marketing, sales, and engineering services (“monthly operating costs”) to EntangleX and Scalova. The Company is committed to $250,000 in expenditures for the EntangleX build-out project which is expected to be completed in three months. The Company is also committed to an estimated $35,000 of monthly operating costs for the support of EntangleX and Scalova ($20,000 for EntangleX and $15,000 for Scalova). Pursuant to the provisions of ASC 350-40, all payments made during the period under this agreement to Ujjwal Roy ($150,000 for EntangleX and $140,000 in operating costs) have been deemed research and development, which we have recorded in general and administrative expense on the condensed consolidated statements of operations and comprehensive income (loss). An additional $100,000 is due on the ExtangleX buildout commitment at September 30, 2026, which is included under accrued liabilities – related party in the condensed consolidated balance sheets.

Deposits

 

On July 14, 2025, the Company entered into a definitive agreement with More Capital Ltd. The purpose of the definitive agreement is to incorporate a new holding company to operate a confection brand and operating company. The definitive agreement includes conditions precedent for the Company to issue 40,000,000 shares of its common stock to More Capital Ltd. and for the Company to transfer $65,000 of cash to More Capital Ltd. As of the date of these financial statements, the shares have not been issued and the cash has not been paid pursuant to the terms of this agreement.

 

 19 
 

On July 28, 2025, the Company entered into a definitive agreement with More Money Ltd. The definitive agreement provides that More Money Ltd. will receive 110,000,000 shares of the Company’s common stock and the Company will transfer $200,000 of cash to More Money Ltd. The CEO transferred 110,000,000 personal shares to satisfy the equity portion of the consideration, and the Company paid $15,992 net advances ($120,000 cash advanced by the Company less repayment from More Money Ltd. of $104,008) and $60,000 in cash at September 30, 2026 and December 31, 2025, respectively. At September 30, 2026, the Company recorded a write-off of advances of $15,992 as the remaining portion of the net advances are not recoverable. On September 30, 2026 and December 31, 2025, $0 and $60,000 are recorded as a deposit on the consolidated balance sheets, respectively.

 

Deposit on Pending IP License Acquisition

On January 23, 2026, the Company entered into an agreement with OnGraph Technologies Limited and/or its affiliates, including DailyLove (collectively “DailyLove”) whereby DailyLove agreed to provide the Company with (i) a license in 100% of the intellectual property (including all software, source code, data, models and documentation) assets related to the AI dating platform (DAILYLOVE.AI) (the” IP Assets”) and (ii) issue a certain number of shares of common stock of DailyLove, all pursuant to terms and conditions of this agreement (“Equity Contingency Consideration”).

In consideration of the IP Assets the Company agreed to pay to DailyLove $500,000 in cash in three installments as follows (i) $125,000 on January 23, 2026 (ii) $125,000 on February 5, 2026 and (iii) $250,000 on February 28, 2026. Upon payment of each installment of cash consideration the Company will receive Equity Contingency Consideration as follows (i) upon payment of the first installment, 2.25% of the total issued and outstanding shares of DailyLove (“DL Shares”) (ii) upon payment of the second installment, 2.25% of the total issued and outstanding DL Shares and (iii) upon payment of the third installment, 4.5% of the total issued and outstanding DL Shares. As of September 30, 2026, the Company recorded Deposits of $261,887 on the balance sheet comprising cash paid to DailyLove of $250,000 and an introductory fee of $11,887 paid to a consultant. None of the Equity Contingency Consideration has been received and the final cash installment of $250,000 has not yet been paid as of the date of these financial statements. Once the terms of the agreement have been fulfilled, we expect to report this transaction as a cost method investment.

NOTE 13 – SUBSEQUENT EVENTS

 

TraderMade Systems Ltd. – Binding Letter of Intent – Related Party Transaction

 

On October 5, 2026, the Company announced the execution of a binding letter of intent (the "LOI") to acquire an 80% interest in United Kingdom-based TraderMade Systems Ltd. ("TraderMade"). Under the terms of the LOI, the Company will acquire an 80% ownership interest in TraderMade from Currency Mountain Holdings, LLC ("CMH"). CMH is owned by Emil Assentato, the Company's Chief Executive Officer. The Company will acquire 80% of TraderMade's issued share capital, alongside all of CMH's rights to a GBP £412,162 receivable (approximately US$544,000), plus accrued interest, owed by TraderMade. The proposed purchase price is US$550,000, payable entirely through the issuance of 550,000,000 shares of common stock at a fixed price of US$0.001 per share. To support the transaction's value, completion requires an independent valuation confirming that the combined value of the acquired shares and the receivable is at least US$550,000. Following closing, the Company intends to commission PCAOB-audited financial statements for TraderMade covering at least its two most recent fiscal years, expected to be delivered within 71 days of closing. Completion of the proposed transaction remains subject to customary closing conditions. There can be no assurance that all conditions will be satisfied or that the transaction will be completed on the terms contemplated.

 

 

 

 

 20 
 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Management's Plan of Operation

 

In June 2025, the Company announced, after fully evaluating the legacy business, the Company is taking steps to reinvigorate it and establish a new pathway in the same business space. The Company will continue to evaluate opportunities both inside and outside the food industry, including, but not limited to, ventures within the fintech and gig economy spaces.

The Company is currently in the process of shifting its focus to becoming a technology company, specifically in the artificial intelligence and quantum computing spaces. The Company’s AI strategy is to address the needs three distinct economies, each of which requires a different solution: personal AI, enterprise automation, and compute frontier through a portfolio of three products: Pegasus, Scalova, and EntangleX. 

On September 30, 2026, pursuant to stockholder consent, our Board of Directors authorized an amendment (the “Amendment”) to our Certificate of Incorporation, as amended, to change the name of the Corporation from Quantum X, Inc. to Quantum X, Inc. The Company filed the Amendment with the Delaware Secretary of State on July 8, 2026. The name change will not be effective until it is cleared by the Financial Industry Regulatory Authority (“FINRA”).

 

On July 7, 2026, the Company voluntarily delisting its common shares from the Canadian Securities Exchange (the "CSE").  The Company’s common shares are no longer listed or posted for trading on the CSE. The Company’s common stock continues to be quoted on the OTC Markets under the symbol “QUTX”. 

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the Financial Statements and accompanying notes. Estimates are used for, but not limited to, the accounting for the allowance for doubtful accounts, impairment of long-term assets, stock-based compensation, derivatives, income taxes and loss contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions.

 

We believe the following critical accounting policies, among others, may be impacted significantly by judgment, assumptions and estimates used in the preparation of the Financial Statements:

 

NET LOSS PER SHARE

 

Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of common shares outstanding for the period increased to include the number of additional common shares that would have been outstanding if potentially dilutive securities had been issued. Dilutive net loss per share for common stock is calculated utilizing the if-converted method which assumes the conversion non-redeemable convertible notes and the line of credit. On September 30, 2026, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible promissory notes of 2,013,730,387 shares as their effect would have been anti-dilutive. On September 30, 2025, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible notes of 1,301,143,126 shares as their effect would have been anti-dilutive.

 

STOCK-BASED COMPENSATION

 

The Company accounts for stock incentive awards issued to employees and non-employees in accordance with ASC 718, “Compensation—Stock Compensation.” . Accordingly, stock-based compensation is measured at the grant date, based on the fair value of the award. Stock-based awards to employees are recognized as an expense over the requisite service period, or upon the occurrence of certain vesting events. Additionally, stock-based awards to non-employees are expensed over the period in which the related services are rendered.

 

 21 
 

DERIVATIVE LIABILITY

 

The Company evaluates the embedded features of its financial instruments, including convertible notes payable, in accordance with ASC 480, “Distinguishing Liabilities from Equity,” and ASC 815, “Derivatives and Hedging.” Certain conversion options and certain contingent features are required to be bifurcated from their host instrument and accounted for separately as derivative financial instruments when applicable criteria are met. The Company applies significant judgment to identify and evaluate complex terms and conditions of its financial instruments to determine whether such instruments are derivatives or contain features that qualify as embedded derivatives.

 

Bifurcated embedded derivatives are recognized at fair value at issuance, with the fair value recorded as a derivative liability and a corresponding debt discount limited to the proceeds received; any excess of the derivative’s fair value over the proceeds is recognized in the condensed consolidated statements of operations at issuance. Debt discounts are amortized to interest expense over the term of the related note. Bifurcated embedded derivatives are remeasured to fair value each reporting period, with changes in fair value recognized in the condensed consolidated statements of operations. Upon conversion, repayment, or extinguishment of the host instrument, the related derivative liability is remeasured to fair value with the change recognized in earnings and is then derecognized as part of the settlement or extinguishment accounting.

 

The fair value of bifurcated embedded derivatives is estimated using a Monte Carlo simulation model incorporating significant unobservable inputs, and such measurements are classified within Level 3 of the fair value hierarchy.

  

COMPARISON OF RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 and 2025

 

Operating expenses:

   Three months ended
September 30,
  Change
   2026
$
  2025
$
  $  %
Salaries and benefits   79,500    82,917    (3,417)   (4)
Occupancy expense   —      10    (10)   (100)
Advertising and travel   (6)   —      (6)     
Auto expenses   —      983    (983)   (100)
Consulting   281,777    67,506    214,271    317 
Depreciation and Amortization   1,555    1,990    (435)   (22)
Bad debt   —      51    (51)   (100)
Office and general expenses   42,065    35,723    6,342    18 
Professional fees   32,150    70,797    (38,647)   (55)
Stock based compensation - services   122,633    —      122,633      
Total operating expenses   559,674    259,977    299,697    115 

 

Our total operating expenses for the three months ended September 30, 2026 was $559,674, compared to $259,977, for the three months ended September 30, 2025, respectively. The increase in total operating expense is primarily due to increase in salaries and benefits, consulting, office and general expenses and stock based compensation.

 

Salaries and benefits for the three months ended September 30, 2026 and 2025, comprise primarily compensation of our officers, directors, and contractor of $79,500 and $82,917, respectively.

 

During the three months ended September 30, 2026 and 2025, consulting expenses of $281,777 and $67,506 consisted of costs related to the development of new businesses including consulting fees paid to Ujjwal Roy, ExtangleX build out costs and Extangle X monthly operating costs.

 

Professional fees comprise legal fees from compliance and the review of proposed transactions and debt agreements, annual audit and filling fees.

 

Stock-based compensation - services for the three months ended September 30, 2026 and 2025, comprise primarily compensation of our contractors of $122,633 and $0, respectively.

 

 22 
 

Other income (expense):

 

   Three months ended
September 30,
  Change
   2026
$
  2025
$
  $  %
Amortization of debt discount and interest expense   (109,763)   (183,629)   73,866    (40)
Loss on settlement of non-redeemable convertible notes and promissory notes   —      (17,181)   (49,003)   (100)
Write-off of advances   (15,992)   —      (15,992)     
Change in fair value of derivative liabilities   8,400    44,451    (36,051)   (81)
Total other income (expenses)   (117,355)   (156,359)   39,004    (25)

 

Amortization of debt discount and interest expense for the three months ended September 30, 2026 was $109,763, compared to $183,629 for the three months ended September 30, 2025. Amortization of debt discount and interest expense relates to the issuance of non-redeemable convertible notes, convertible notes and promissory notes. During the year ended December 31, 2025, the Company issued shares of common to stock to settle convertible notes, promissory notes and a line of credit which resulted in a decrease in amortization of debt discount and interest expense during three months ended September 30, 2026.

 

Net loss for the period:

   Three months ended
September 30,
  Change
   2026
$
  2025
$
  $  %
Net loss for the period   (677,029)   (416,336)   (260,693)   63 

 

Our net loss for the three months ended September 30, 2026 was $677,029, compared to $416,336 for the three months ended September 30, 2025, respectively. Our losses during the three months ended September 30, 2026 and 2025 are primarily due to costs associated with compensation to our officers and directors, consulting, professional fees, stock based compensation, interest, offset by a decrease in fair value of derivative liabilities.

 

 23 
 

COMPARISON OF RESULTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 and 2025

 

Operating expenses:

   Nine months ended
September 30,
  Change
   2026
$
  2025$  $  %
Salaries and benefits   238,500    212,917    25,583    12 
Occupancy expense   —      1,287    (1,287)   (100)
Advertising and travel   1,123    —      1,123      
Auto expenses   —      983    (983)   (100)
Consulting   539,143    101,458    437,685    431 
Depreciation and Amortization   2,273    7,941    (5,668)   (71)
Bad debt   —      6,611    (6,611)   (100)
Office and general expenses   130,998    68,461    62,537    91 
Professional fees   228,841    324,990    (96,149)   (30)
Stock based compensation   773,415    —      773,415      
Stock based compensation-salaries   957,500    —      957,500      
Total operating expenses   2,871,793    724,648    2,147,145    296 

 

Our total operating expenses for the nine months ended September 30, 2026 was $2,871,793, compared to $724,648, for the nine months ended September 30, 2025, respectively. The increase in total operating expense is primarily due to increase in salaries and benefits, consulting, office and general expenses and stock based compensation, offset by decrease in professional fees.

 

Salaries and benefits for the nine months ended September 30, 2026 and 2025, comprise primarily compensation of our officers, directors, and contractor of $238,500 and $212,917, respectively.

 

During the nine months ended September 30, 2026 and 2025, consulting expenses of $539,143 and $101,458 consisted of costs related to the development of new businesses including consulting fees paid to Ujjwal Roy,
ExtangleX build out costs and Extangle X monthly operating costs.

 

Professional fees comprise legal fees from compliance and the review of proposed transactions and debt agreements, annual audit and filling fees.

 

Stock-based compensation - services for the nine months ended September 30, 2026 and 2025, comprise primarily compensation of our contractors of $773,415 and $0, respectively.

 

Other income (expense):

 

   Nine months ended
September 30,
  Change
   2026
$
  2025
$
  $  %
Amortization of debt discount and interest expense   (230,595)   (321,941)   91,346    (28)
Gain (loss) on settlement of non-redeemable convertible notes and promissory notes   5,272    (17,181)   22,453    (131)
Initial derivative expense   (33,804)   (235,220)   201,416    (86)
Change in fair value of derivative liabilities   219,239    215,904    3,335    2 
Write-off of advances   (15,992)   —      (15,992)     
Total other income (expenses)   (55,880)   (358,438)   302,558    (84)

 

 24 
 

Amortization of debt discount and interest expense for the nine months ended September 30, 2026 was $230,595, compared to $321,941 for the nine months ended September 30, 2025. Amortization of debt discount and interest expense relates to the issuance of non- redeemable convertible notes, convertible notes and promissory notes. During the year ended December 31, 2025, the Company issued shares of common to stock to settle convertible notes, promissory notes and a line of credit which resulted in a decrease in amortization of debt discount and interest expense during nine months ended September 30, 2026.

 

Initial derivative expense of $33,804 for the nine months ended September 30, 2026 represents the difference between the fair value of the total embedded derivative liability of $113,804 and the cash received of $80,000 for convertible note issued on January 16, 2026 .

 

Gain on debt settlement for the nine months ended September 30, 2026 of $5,272, is comprised of the difference between the carrying value of convertible promissory notes, net and derivative liabilities settled of $279,760 and the cash paid of $274,488 for convertible notes issued on November 13, 2025 and December 2, 2025.

 

Net loss for the period:

   Nine months ended
September 30,
  Change
   2026
$
  2025
$
  $  %
Net loss for the period   (2,927,672)   (1,083,086)   (1,844,587)   170 

 

Our net loss for the nine months ended September 30, 2026 was $2,927,672, compared to $1,083,086 for the nine months ended September 30, 2025, respectively. Our losses during the nine months ended September 30, 2026 and 2025 are primarily due to costs associated with compensation to our officers and directors, consulting, professional fees, interest, and change in fair value of derivative liabilities.

  

QUARTERLY RESULTS OF OPERATIONS

 

The following is a summary of selected quarterly information that has been derived from the financial statements of the Company. This summary should be read in conjunction with the consolidated financial statements of the Company.

 

Quarter Ended  September 30,
2026
  June 30,
2026
  March 31,
2026
  December 31,
2025
  September 30,
2025
  June 30,
2025
  March 31,
2025
  December 31,
2024
Sales  $—     $—     $—     $—     $—     $—     $—     $140,258 
Gross profit  $—     $—     $—     $—     $—     $—     $—     $(34,216)
Operating expenses  $(559,674)  $(2,076,433)  $(235,686)  $(332,678)  $(259,977)  $(207,602)  $(257,069)  $(299,791)
Other income (expense)  $(117,355)  $(109,976)  $171,452   $930,910   $(156,359)  $(128,716)  $(73,363)  $(489,659)
Net income (loss) for the period  $(677,029)  $(2,186,409)  $(64,234)  $598,232   $(416,336)  $(336,318)  $(330,432)  $(823,666)
Basic and diluted net income (loss) per share  $(0.00)  $(0.00)  $(0.00)  $(0.00)  $(0.00)  $(0.00)  $(0.00)  $(0.00)

 

 

 

 

 25 
 

LIQUIDITY AND CAPITAL RESOURCES

 

For the nine months ended September 30, 2026

 

Cash flows used in operating activities

 

   Nine months ended
September 30,
  Change
   2026
$
  2025
$
  $  %
Net cash used in operating activities   (868,710)   (492,840)   (375,870)   76 

 

Our net cash used in operating activities for the nine months ended September 30, 2026 and 2025 is $860,710 and $492,840, respectively. Our net loss for the nine months ended September 30, 2026 of $2,927,672 and change in fair value of derivative liabilities of $219,239 was the main contributing factors for our negative cash flow. We were able to partially offset the cash used in operating activities with non-cash expenses such as stock-based compensation, amortization of debt discount and initial derivative expense.

 

Cash flows used in investing activities

 

   Nine months ended
September 30,
  Change
   2026
$
  2025
$
  $
Net cash used in investing activities   (387,879)   —      (367,879)

 

Our net cash used in investing activities for the nine months ended September 30, 2026 and 2025 is $387,879 and $0, respectively. During the nine months ended September 30, 2026, we purchased of graphics processing unit we made deposits on contractual commitments related to our More Money, EntangleX and DailyLove projects and capitalized software development costs related to our Scalova project.

 

Cash flows from financing activities

 

   Nine months ended
September 30,
  Change
   2026
$
  2025
$
  $  %
Net cash provided by financing activities   1,108,512    500,688    607,824    121 

 

Our net cash provided by financing activities for the nine months ended September 30, 2026 and 2025, is $1,108,512 and $500,688, respectively.

 

During the nine months ended September 30, 2026 and 2025, the Company received cash advances from related party of $998,000 and $428,100, respectively. These cash advances earns interest at 8% per annum, is unsecured and is due on demand.

 

As of September 30, 2026, we had cash of $79,508, working capital (deficiency) of $(3,065,331) and total liabilities of $3,317,475.

 

Our working capital as of September 30, 2026 and December 31, 2025 is as follows:

 

   September 30,
2026
  December 31,
2025
Current assets  $246,160   $254,236 
Current liabilities   3,311,491    2,264,701 
Working capital (Deficiency)  $(3,065,331)  $(2,010,465)

 

 26 
 

The Company is continuing to focus improving cash flows from operations reducing expenses, managing accounts payable balances and by paying our officers, directors, consultants and staff with our stock.

 

The Company’s financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. During the nine months ended September 30, 2026, the Company incurred a net loss of $2,927,672 and used cash in operating activities of $868,710, and on September 30, 2026, had stockholders’ deficit of $2,631,455 and an accumulated deficit of $97,932,674. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The Company’s independent registered public accounting firm, in their report on the Company’s financial statements for the year ended December 31, 2025, contains an explanatory paragraph regarding the Company’s ability to continue as a going concern. The Company’s financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern.

 

Over the next 12 months we expect to spend approximately $1,070,000 in cash for operations, legal, accounting, and related services and to implement our business plan. We hope to be able to compensate our independent contractors with stock-based compensation, which will not require us to use our cash, although there can be no assurances that we will be successful in these efforts.

 

    Cash Required to Implement of Business Plan
General and Administration $ 300,000
Scalova/EntangleX buildout and monthly operating costs (Note 8)   520,000
DailyLove agreement (Note 10)   250,000
Total Estimated Cash Expenditures $ 1,070,000

 

We expect to be able to secure additional capital through advances from our Chief Executive Officer in order to pay expenses such as organizational costs, filing fees, accounting fees and legal fees, however, we do not have any written or oral agreements with any other third parties which require them to fund our operations. We are currently in discussions with investors for private loans and an equity line of credit. Although there can be no assurances that we will be able to obtain such funds in the future, the Company has been able to secure financing to continue operations since its inception on April 3, 2009. We are currently quoted on OTC Pink.. If we need additional capital in the next twelve months and if we cannot raise such capital on acceptable terms, we may have to curtail our operations or terminate our business entirely.

 

The inability to obtain financing or generate sufficient cash from operations could require us to reduce or eliminate expenditures for developing products and services, or otherwise curtail or discontinue our operations, which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, to the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities may result in dilution to existing stockholders. If we raise additional funds through the issuance of debt securities, these securities may have rights, preferences and privileges senior to holders of our common stock and the terms of such debt could impose restrictions on our operations. Regardless of whether our cash assets prove to be inadequate to meet our operational needs, we may seek to compensate providers of services by issuing stock in lieu of cash, which may also result in dilution to existing stockholders.

 

Our common stock started trading over the counter and has been quoted on the Over-The Counter Bulletin Board since February 17, 2011. The stock currently trades under the symbol “QUTX”.

 

Commitments for future capital expenditures at September 30, 2026 is as follows:

 

   Payments Due by Period
Contractual obligations  Total
$
  Less than 1 year
$
  1 - 3 years
$
  4 – 5 years
$
  After 5 years
$
Accounts payable and accrued liabilities   749,579    749,579    —      —      —   
Debt   2,074,513    2,074,513    —      —      —   
Non-redeemable convertible notes   137,951    137,951    —      —      —   
Convertible promissory notes, net   135,948    135,948    —      —      —   
Derivative liabilities   213,500    213,500    —      —      —   
Operating leases   —      —      —      —      —   
Total contractual obligations   3,311,491    3,311,491    —      —      —   

 

 27 
 

OPERATING CAPITAL AND CAPITAL EXPENDITURE REQUIREMENTS

 

We expect to be able to secure additional capital through advances from our Chief Executive Officer in order to pay expenses such as organizational costs, filing fees, accounting fees and legal fees, however, we do not have any written or oral agreements with any other third parties which require them to fund our operations. We are currently in discussions with investors for private loans and an equity line of credit. Although there can be no assurances that we will be able to obtain such funds in the future, the Company has been able to secure financing to continue operations since its inception on April 3, 2009. We are currently quoted on OTC Pink. If we need additional capital in the next twelve months and if we cannot raise such capital on acceptable terms, we may have to curtail our operations or terminate our business entirely.

 

Our common stock started trading over the counter and has been quoted on the Over-The Counter Bulletin Board since February 17, 2011. The stock currently trades under the symbol “QUTX”.

 

RELATED PARTY TRANSACTIONS

 

Nine months ended September 30, 2026 and 2025

 

Non-redeemable Convertible Notes – Related Party

 

On September 13, 2018, the Company entered into a Side Letter Agreement (“Original Note”) with a non-related investor, Jordan Turk, to amend and add certain terms to unsecured, non-interest bearing, due on demand notes payable totaling $40,000 issued by the Company during the period of July 10, 2018 to September 13, 2018. The issue price of the Note is $40,000 with a face value of $48,000 and the Note has an original maturity date of December 31, 2018 which is subject to automatic annual renewal. On June 29, 2021, the Company and Jordan Turk entered into an Agreement to change the original maturity date of the Note to December 31, 2025. At the option of the Company, the Company may convert principal and interest at a fixed conversion price of $0.0001 per share of the Company’s common stock. The Note allows the lender to secure a portion of the Company assets up to 200% of the face value of the Note. If the Note is not paid on December 31 each year, the outstanding face amount of the Note increases by 20% on January 1 the following year.

 

On December 30, 2024, Jordan Turk and the Company agreed to exchange $43,328 of principal and interest of Original Note for a New Promissory Note with a carrying value of $71,993 resulting in a loss of extinguishment of $28,665.

 

Also, on December 30, 2024, Jordan Turk entered into an agreement to assign the remaining outstanding principal and interest of the Original Note with a carrying value of $100,000 to Emil Assentato, the Chief Executive Officer of the Company.

 

The consolidated statement of operations includes amortization of debt discount of $17,951 and $14,959 for the nine months ended September 30, 2026 and 2025, respectively, due to the 20% increase in face value on January 1 each year. On September 30, 2026 and December 31, 2025, the carrying amount of the Note is $137,951 (face value of $144,000 less $6,049 unamortized discount) and $120,000 (face value of $120,000 less $0 unamortized discount), respectively.

 

 

 28 
 

Promissory Notes – Related Party

 

On September 30, 2026 and December 31, 2025, $1,959,777 (comprising of $1,851,100 of advances and $108,677 of interest) and $882,632 (comprising of $853,100 of advances and $29,532 of interest), respectively was due to Emil Assentato, the Company's Chief Executive. During nine months ended September 30, 2026, the Company issued total advances for $998,000 comprising $998,000 for cash received and $0 of expenses paid on behalf of the Company. This note payable – related party earns interest at 8% per annum, is unsecured and is due on demand.

 

Software Development Agreement

On May 1, 2026, the Company entered into a contract with Ujjwal Roy, the Head of Strategy of the Company, to (a) complete the build-out of the user face for EntangleX and (b) provide ongoing maintenance, operations, marketing, sales, and engineering services (“monthly operating costs”) to EntangleX and Scalova. The Company is committed to $250,000 in expenditures for the EntangleX build-out project which is expected to be completed in three months. The Company is also committed to an estimated $35,000 of monthly operating costs for the support of EntangleX and Scalova ($20,000 for EntangleX and $15,000 for Scalova). Pursuant to the provisions of ASC 985-20, all payments made during the period under this agreement to Ujjwal Roy ($150,000 for EntangleX and $140,000 in operating costs) have been deemed research and development, which we have recorded in general and administrative expense on the condensed consolidated statements of operations and comprehensive income (loss).

Our policy with regard to transactions with related persons or entities is that such transactions must be on terms no less favorable than could be obtained from non-related persons.

 

The above related party transactions are not necessarily indicative of the amounts that would have been incurred had a comparable transaction been entered into with an independent party.

 

PROPOSED TRANSACTIONS

 

The Company is not anticipating any transactions.

 

CHANGES IN ACCOUNTING POLICIES INCLUDING INITIAL ADOPTION

 

Refer to Note 2 in the consolidated financial statements for the year ended December 31, 2025 for information on accounting policies.

 

FINANCIAL INSTRUMENTS

 

The main risks of the Company’s financial instrument are exposed to are credit risk, market risk, foreign exchange risk, and liquidity risk.

 

Credit risk

 

The Company’s credit risk is primarily attributable to trade receivables. The Company mitigates credit risk through approvals, limits and monitoring. The amounts disclosed in the consolidated balance sheet are net of allowances for expected credit losses, estimated by the Company’s management based on past experience and specific circumstances of the customer. The Company manages credit risk for cash by placing deposits at major financial institutions.

 

Market risk

 

Market risk is the risk that changes in market prices and interest rates will affect the Company’s net earnings or the value of financial instruments. These risks are generally outside the control of the Company. The objective of the Company is to mitigate market risk exposures within acceptable limits, while maximizing returns. The Company’s market risk consists of risks from changes in foreign exchange rates, interest rates and market prices that affect its financial liabilities, financial assets and future transactions.

 

Refer to Note 2 in the consolidated financial statements for the year ended December 31, 2025 and Note 2 in the consolidated financial statements for the year ended December 31, 2025 for information on market risk.

 

Foreign Exchange risk

 

We pay expenses in Canadian dollars from operations in Canada. Our consolidated financial statements are presented in U.S. dollars and our liabilities other than trade payables are primarily due in U.S. dollars.

 29 
 

Liquidity risk

 

Liquidity risk relates to the risk the Company will encounter difficulty in meeting its obligations associated with financial liabilities. The financial liabilities on our consolidated balance sheets consist of accounts payable and accrued liabilities, due to related party, notes payable, convertible notes, net, derivative liabilities, promissory notes, promissory notes – related party and non-redeemable convertible notes, Management monitors cash flow requirements and future cash flow forecasts to ensure it has access to funds through its existing cash and from operations to meet operational and financial obligations

 

OUTSTANDING SHARE DATA

 

As of November 11, 2026, the following securities were outstanding:

 

Common stock 7,697,746,967 shares

 

OFF-BALANCE SHEET TRANSACTIONS

 

We currently have no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a Smaller Reporting Company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

As required by Rule 13a-15 of the Securities Exchange Act of 1934, our principal executive officer and principal financial officer evaluated our company's disclosure controls and procedures (as defined in Rules 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of the end of the period covered by this report, these disclosure controls and procedures were not effective to ensure that the information required to be disclosed by our company in reports it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities Exchange Commission and to ensure that such information is accumulated and communicated to our company's management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. The conclusion that our disclosure controls and procedures were not effective was due to the presence of the following material weaknesses in internal control over financial reporting which are indicative of many small companies with small staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both United States generally accepted accounting principles and Securities and Exchange Commission guidelines. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.

 

We plan to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending December 31, 2026, subject to obtaining additional financing: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out above are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.

 

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.

 

CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

 

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2026 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 30 
 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

We may be involved from time to time in ordinary litigation, negotiation and settlement matters that will not have a material effect on our operations or finances. We are not aware of any pending or threatened litigation against our Company or our officers and directors in their capacity as such that could have a material impact on our operations or finances.

 

ITEM 1A. RISK FACTORS

 

A smaller reporting company is not required to provide the information required by this Item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

During the nine months ended September 30, 2026, the Company issued an aggregate of 478,289,474 shares of the Company’s common stock with a fair value of $957,500 ($0.002 per share) pursuant to the Company’s 2026 Stock Incentive Plan. The shares were issued to certain officers, directors and consultants of the Company in consideration for services rendered pursuant to the terms of the Plan and applicable award agreements.

 

During the nine months ended September 30, 2026, the Company issued an aggregate of 315,000,000 shares of the Company’s common stock with a fair value of $625,000 ($0.002 per share) for services pursuant to the Company’s 2026 Stock Incentive Plan.

 

During the nine months ended September 30, 2026, the Company issued 210,000,000 shares of common stock of the Company for consulting and corporate advisory services with a fair value of $283,000 ($0.0013 per share) which was included in prepaid expenses. Prepaid expenses are amortized over periods from nine months to twelve months.

 

During the nine months ended September 30, 2026, the Company returned to treasury and cancelled 77,627,224 shares of common stock.

 

During the nine months ended September 30, 2026, the Company issued 134,210,526 shares of the Company’s common stock with a fair value of $255,000 ($0.0019 per share) pursuant to the Company’s 2026 Stock Incentive Plan to settle accrued liabilities – related party due to Emil Assentato, the Chief Executive Officer of the Company.

 

During the nine months ended September 30, 2026, the Company issued 136,364,500 shares of the Company’s common stock with a fair value of $168,103 ($0.0012 per share) for conversion of the convertible promissory notes. The conversions resulted in the settlement of derivative liabilities of $58,700 and a loss on settlement of debt of $66,184.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

During the quarter ended September 30, 2026, we did not have any defaults upon senior securities.

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

During the quarter ended September 30, 2026, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements.

 31 
 

ITEM 6. EXHIBITS

      Incorporated by reference
Exhibit Exhibit Description Filed herewith Form Period ending Exhibit Filing date
3.1 Certificate of Incorporation, dated April 3, 2009   S-1   3.1 6/22/2010
3.2 Bylaws, dated April 3, 2009   S-1   3.2 6/22/2010
3.3 Certificate of Amendment to the Certificate of Incorporation, dated August 8, 2013   10-Q 6/30/2013 3.3 8/14/2013
3.4 Certificate of Amendment to the Certificate of Incorporation, dated July 27, 2016   8-K 9/1/2016 3.1 9/1/2016
3.5 Certificate of Amendment to the Certificate of Incorporation, dated August 27, 2018   8-K 9/10/2018 3.1 9/10/2018
3.6 Certificate of Amendment to the Certificate of Incorporation, dated November 18, 2019   8-K 12/12/2019 3.1 12/12/2019
3.7 Certificate of Amendment to the Certificate of Incorporation, dated July 16, 2021   8-K 7/16/2021 3.1 7/22/2021
3.8 Certificate of Amendment to the Certificate of Incorporation, dated January 3, 2022   8-K 1/3/2022 3.1 1/6/2022
3.9

Certificate of Amendment to the Certificate of Incorporation, As Amended, dated

March 21, 2022

  8-K 4/25/2022 3.1 4/26/2022
3.10

Certificate of Amendment to the Certificate of Incorporation, As Amended, filed with the Delaware Secretary of State on August 22, 2023.

  8-K 9/8/2023 3.1 9/11/2023
4.1 Specimen Stock Certificate   S-1   4.1 6/22/2010
4.2 Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, dated August 6, 2013   10-Q 6/30/2013 4.2 8/14/2013
4.3 Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock, dated December 12, 2019  

8-K

 

12/12/2019

 

3.1

 

12/19/2019

 

4.4 Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated October 7, 2020   8-K 10/07/2020 3.1 10/08/2020
4.5 Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated June 24, 2021      8-K 6/24/2021 3.1 7/1/2021
4.6 Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock, dated September 1, 2021   8-K 9/1/2021 3.1 9/1/2021
4.7 Amended and Restated Designation of Series A Convertible Preferred Stock of Two Hands Corporation, dated April 21, 2022   8-K 4/21/2022 3.1 4/26/2022
4.8 Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, dated July 5, 2022  10-Q  6/30/2022  4.8 8/15/2022 
4.9 Certificate of Designation, Preference and Rights of Series E Preferred Stock, dated October 3, 2022   8-K 10/4/2022 3.1 10/11/2022
10.1 Innovative Product Opportunities Inc. Trust Agreement   S-1   10.1 6/22/2010
10.2 Side Letter Agreement, The Cellular Connection Ltd., dated January 8, 2018   10-K 12/31/2017 10.2 3/29/2018
10.3 Side Letter Agreement, Stuart Turk, dated January 8, 2018   10-K 12/31/2017 10.3 3/29/2018
10.4 Side Letter Agreement, Jordan Turk, dated April 12, 2018   10-Q 3/31/2018 10.4 5/21/2018
10.5 Side Letter Agreement, Jordan Turk, dated May 10, 2018   10-Q 3/31/2018 10.5 5/21/2018
10.6 Side Letter Agreement, Jordan Turk, dated September 13, 2018   10-K

12/31/2018

 

10.6 4/1/2019
10.7 Side Letter Agreement, The Cellular Connection Ltd., dated January 31, 2019   10-K 12/31/2018 10.7 4/1/2019
10.8 Side Letter Agreement, Stuart Turk, dated January 31, 2019   10-K 12/31/2018 10.8 4/1/2019
19.1 Insider Trading Policy 10-K 12/31/2024   19.1  4/14/2025
31.1 Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X        
31.2 Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X        
32.1* Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X        
32.2* Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X        
101.INS XBRL Instance Document – the instance document does not appear in the Interactive Data Files as its XBRL tags are embedded within the Inline XBRL document X        
101.SCH XBRL Taxonomy Extension Schema Document X        
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document X        
101.LAB XBRL Taxonomy Extension Label Linkbase Document X        
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document X        
101.DEF XBRL Taxonomy Extension Definition Linkbase Definition X        
104 Cover page formatted as Inline XBRL and contained in Exhibit 101 X        

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under those sections.

 32 
 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    QUANTUM X, INC.
     
Dated: November 16, 2026  

By: /s/ Emil Assentato

Name: Emil Assentato

Title: President, Chief Executive Officer and Director

(Principal Executive Officer)

     
   

By: /s/ Matthew Stark

Name: Matthew Stark

Title: Chief Financial Officer and Director

(Principal Financial and Accounting Officer)

     
     

  

 

 

 33 

 

Keep reading